Wire-ready dashboard awaiting your first source connection.
| Details | Saved | Published | Title | Source | Tickers |
|---|---|---|---|---|---|
|
2025-11-03 06:20
5mo ago
|
2025-11-03 01:00
6mo ago
|
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting | stocknewsapi |
MOLN
|
|
|
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will present updated data from a Phase 1/2a trial of MP0533, a novel, multispecific T cell engager for acute myeloid leukemia (AML) patients, in a poster at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 6-9, 2025, in Orlando, Florida, and online.
|
|||||
|
2025-11-03 06:20
5mo ago
|
2025-11-03 01:00
6mo ago
|
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025 | stocknewsapi |
MOLN
|
|
|
November 03, 2025 01:00 ET
| Source: Molecular Partners Poster presentation outlines potential of CD3 Switch-DARPin T cell engager (TCE) using an AND-gate to overcome limitations of other TCEs Demonstrated selective T cell cytotoxicity against cells co-expressing tumor-associated antigens MSLN and EpCAM Induced significant tumor regression in vivo without causing systemic cytokine release, indicating favorable safety profile ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will present further preclinical proof-of-concept data on its logic-gated CD3 Switch-DARPin T cell engager (TCE) with CD2 co-stimulation in a poster at the Society for Immunotherapy of Cancer (SITC) 2025 meeting, taking place in National Harbor, MD, USA from November 5-9. Clinical development of TCEs for solid tumors is often limited by systemic toxicity in the absence of specific enough tumor antigens and by impaired efficacy due to insufficient T cell activity. To address this, Molecular Partners designed a logic-gated Switch-DARPin TCE using an AND-gate to achieve conditional tumor-localized immune activation targeting mesothelin (MSLN) and epithelial cell adhesion molecule (EpCAM), which are highly co-expressed in ovarian cancer and other solid tumors. The Switch-DARPin TCE is designed for the CD3-engaging DARPin to be unmasked (“Switch” on) and activate T cells only upon binding to both MSLN and EpCAM (AND-gate). Preclinical data to be presented at SITC show that the Switch-DARPin demonstrated selective T cell cytotoxicity against cells co-expressing both tumor-associated antigens, with attenuated activity against cells in healthy tissues expressing only MSLN or only EpCAM. In addition, T cells repetitively exposed to CD2/CD3 Switch-DARPin showed a fundamentally improved activation and proliferation profile as compared to CD3 engagement alone, highlighting the potential of CD2/CD3 Switch-DARPin to overcome T cell exhaustion. Finally, the Switch-DARPin induced significant tumor regression in a xenograft mouse model expressing MSLN and EpCAM without causing systemic cytokine release, indicating a favorable safety profile. “These data further underline the potential of Molecular Partners’ wholly-owned logic-gated and co-stimulated T cell engager program, which allows for targeted, conditional immune activation only in the presence of defined targets. The Switch-DARPin only activates T cells when both tumor-associated antigens are bound, and remains inactive in circulation, which allows the addition of a CD2 DARPin for co-stimulation of T cells. This approach is an opportunity for novel cancer treatments through logic-gated tumor-directed immune activation with increased efficacy and safety over modalities targeting a single tumor antigen,” said Martin Steegmaier, Ph.D., CSO of Molecular Partners. Details of the presentation Title: A next-generation conditional Switch-DARPin T cell engager with CD2 co-stimulation enabling selective activity against solid tumors which co-express mesothelin (MSLN) and EpCAM Abstract number: 829 Time: November 7, 2025 Location: Gaylord National Resort and Convention Center - Lower Level Atrium - Prince George's ABC About DARPin Therapeutics DARPin (Designed Ankyrin Repeat Protein) therapeutics are a new class of custom-built protein drugs based on natural binding proteins that open new dimensions of multi-functionality and multi-target specificity in drug design. The flexible architecture, intrinsic potential for high affinity and specificity, small size and high stability of DARPins offer benefits to drug design over other currently available protein-based therapeutics. DARPin candidates can be radically simple, with a single DARPin unit acting as the delivery vector to a specific target; or multispecific, with the possibility of engaging more than five targets, and combining multiple and conditional functionalities in a unique DARPin drug candidate. The DARPin platform is designed to be a rapid and cost-effective drug discovery engine, producing drug candidates with optimized properties and high production yields. DARPin therapeutics have been clinically validated across several therapeutic areas and developed through to the registrational stage. About Molecular Partners AG Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN) is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics for medical challenges other drug modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zurich, Switzerland and Concord, MA, USA. For more information, visit www.molecularpartners.com and find us on LinkedIn and Twitter / X @MolecularPrtnrs For further details, please contact: Seth Lewis, SVP Investor Relations & Strategy Concord, Massachusetts, U.S. [email protected] Tel: +1 781 420 2361 Laura Jeanbart, PhD, Head of Portfolio Management & Communications Zurich-Schlieren, Switzerland [email protected] Tel: +41 44 575 19 35 Cautionary Note Regarding Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, as amended, including without limitation: implied and express statements regarding the clinical development of Molecular Partners’ current or future product candidates; expectations regarding timing for reporting data from ongoing clinical trials or the initiation of future clinical trials; the potential therapeutic and clinical benefits of Molecular Partners’ product candidates and its RDT and Switch-DARPin platforms; the selection and development of future programs; Molecular Partners’ collaboration with Orano Med including the benefits and results that may be achieved through the collaboration; and Molecular Partners’ expected business and financial outlook, including anticipated expenses and cash utilization for 2025 and its expectation of its current cash runway. These statements may be identified by words such as “aim”, "anticipate”, “expect”, “guidance”, “intend”, “outlook”, “plan”, “potential”, “will” and similar expressions, and are based on Molecular Partners’ current beliefs and expectations. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Some of the key factors that could cause actual results to differ from Molecular Partners’ expectations include its plans to develop and potentially commercialize its product candidates; Molecular Partners’ reliance on third party partners and collaborators over which it may not always have full control; Molecular Partners’ ongoing and planned clinical trials and preclinical studies for its product candidates, including the timing of such trials and studies; the risk that the results of preclinical studies and clinical trials may not be predictive of future results in connection with future clinical trials; the timing of and Molecular Partners’ ability to obtain and maintain regulatory approvals for its product candidates; the extent of clinical trials potentially required for Molecular Partners’ product candidates; the clinical utility and ability to achieve market acceptance of Molecular Partners’ product candidates; the potential that Molecular Partners’ product candidates may exhibit serious adverse, undesirable or unacceptable side effects; the impact of any health pandemic, macroeconomic factors and other global events on Molecular Partners’ preclinical studies, clinical trials or operations, or the operations of third parties on which it relies; Molecular Partners’ plans and development of any new indications for its product candidates; Molecular Partners’ commercialization, marketing and manufacturing capabilities and strategy; Molecular Partners’ intellectual property position; Molecular Partners’ ability to identify and in-license additional product candidates; unanticipated factors in addition to the foregoing that may cause Molecular Partners’ actual results to differ from its financial and business projections and guidance; and other risks and uncertainties set forth in Molecular Partners’ Annual Report on Form 20-F for the year ended December 31, 2024 and other filings Molecular Partners makes with the SEC from time to time. These documents are available on the Investors page of Molecular Partners’ website at www.molecularpartners.com. In addition, this press release contains information relating to interim data as of the relevant data cutoff date, results of which may differ from topline results that may be obtained in the future. Any forward-looking statements speak only as of the date of this press release and are based on information available to Molecular Partners as of the date of this release, and Molecular Partners assumes no obligation to, and does not intend to, update any forward-looking statements, whether as a result of new information, future events or otherwise. |
|||||
|
2025-11-03 06:20
5mo ago
|
2025-11-03 01:01
6mo ago
|
IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts | stocknewsapi |
IDXX
|
|
|
IDEXX Laboratories, Inc. (NASDAQ:IDXX) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 3.
Analysts expect the Westbrook, Maine-based company to report quarterly earnings at $3.14 per share, up from $2.80 per share in the year-ago period. The consensus estimate for IDEXX Laboratories' quarterly revenue is $1.07 billion, compared to $975.54 million a year earlier, according to data from Benzinga Pro. On Aug. 4, IDEXX Laboratories reported better-than-expected second-quarter financial results and raised its FY25 guidance above estimates. Shares of IDEXX Laboratories rose 0.2% to close at $629.51 on Friday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables. Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period. Stifel analyst Jonathan Block upgraded the stock from Hold to Buy and raised the price target from $640 to $700 on Oct. 31, 2025. This analyst has an accuracy rate of 72%. UBS analyst Andrea Alfonso initiated coverage on the stock with a Neutral rating and a price target of $720 on Oct. 1, 2025. This analyst has an accuracy rate of 78%. Morgan Stanley analyst Erin Wright maintained an Overweight rating and increased the price target from $722 to $765 on Aug. 15, 2025. This analyst has an accuracy rate of 73%. Piper Sandler analyst David Westenberg maintained a Neutral rating and increased the price target from $510 to $700 on Aug. 11, 2025. This analyst has an accuracy rate of 73%. JP Morgan analyst Chris Scott maintained an Overweight rating and raised the price target from $550 to $675 on Aug. 4, 2025. This analyst has an accuracy rate of 62% Considering buying IDXX stock? Here’s what analysts think: Read This Next: Wall Street’s Most Accurate Analysts Spotlight On 3 Industrials Stocks With Over 6% Dividend Yields Photo via Shutterstock Market News and Data brought to you by Benzinga APIs © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. |
|||||
|
2025-11-03 06:20
5mo ago
|
2025-11-03 01:03
6mo ago
|
MUFG-backed climate loan fund raises initial $600 million | stocknewsapi |
MUFG
|
|
|
SummaryCompaniesGAIA Climate Loan Fund aims to raise $1.5 blnInvestors include FinDev Canada, Green Climate FundAt least 70% of money to finance adaptation projectsLONDON, Nov 3 (Reuters) - A climate finance platform co-founded by MUFG
(8306.T), opens new tab, Japan's biggest financial group, has raised an initial $600 million to help countries in developing markets adapt to the impacts of climate change and cut emissions, executives told Reuters. The announcement comes as business leaders gather in Brazil ahead of the COP30 climate talks with countries being urged to do more to close a UN-estimated finance gap of $300 billion a year, including by billionaire investor Bill Gates. Sign up here. As extreme weather events such as floods and droughts increase in intensity, the GAIA Climate Loan Fund would primarily aim to back projects that help countries build resilience. "Adaptation Finance is a topic that has been on the rise at the last few COPs," said Ariane Pevide, Director, Climate and Blended Finance at MUFG, in emailed comments. "We hope that the close of GAIA will strengthen the argument for private sector capital, focused on adaptation as a blueprint for the market." FinDev Canada, Canada's development finance body, and the Green Climate Fund, the world's biggest dedicated climate fund, also provided investments and the fund aims to grow to $1.5 billion. "We are in discussions with impact-minded institutional investors, including insurance companies, pension funds and family offices, to reach the target size," said Amit Mohan, Head of Private Credit at Climate Fund Managers, which runs the fund. The fund works by providing long-term loans to sovereign, sub- and quasi-sovereign and state-owned entities across 19 countries, the founders said in a statement. At least 70% of the money will go to adaptation projects, such as sustainable agriculture and water management, with the rest on mitigation efforts such as renewable energy. Once fully deployed, it aims to benefit 19 million people and create more than 11,000 jobs, avoiding 30 million tons of greenhouse gases a year. Reporting by Simon Jessop; Editing by Toby Chopra Our Standards: The Thomson Reuters Trust Principles., opens new tab Simon leads a team tracking how the financial system and companies more broadly are responding to the challenges posed by climate change, nature loss and other environmental, social and governance (ESG) issues including diversity and inclusion. |
|||||
|
2025-11-03 06:20
5mo ago
|
2025-11-03 01:08
6mo ago
|
El Pollo Loco: The Dark Horse Of Small-Cap Restaurants | stocknewsapi |
LOCO
|
|
|
Analyst’s Disclosure:I/we have a beneficial long position in the shares of LOCO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-03 06:20
5mo ago
|
2025-11-03 01:10
6mo ago
|
Molina Healthcare, Inc. (MOH) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Robbins Geller Rudman & Dowd LLP | stocknewsapi |
MOH
|
|
|
, /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), have until Tuesday, December 2, 2025 to seek appointment as lead plaintiff of the Molina class action lawsuit. Captioned Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.), the Molina Healthcare class action lawsuit charges Molina Healthcare as well as certain of Molina Healthcare's top executives with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Molina Healthcare class action lawsuit, please provide your information here: https://www.rgrdlaw.com/cases-molina-healthcare-inc-class-action-lawsuit-moh.html You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. CASE ALLEGATIONS: Molina Healthcare provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. The Molina Healthcare class action lawsuit alleges that defendants throughout the Class Period failed to disclose: (i) material, adverse facts concerning Molina Healthcare's "medical cost trend assumptions"; (ii) that Molina Healthcare was experiencing a "dislocation between premium rates and medical cost trend"; (iii) that Molina Healthcare's near term growth was dependent on a lack of "utilization of behavioral health, pharmacy, and inpatient and outpatient services"; and (iv) as a result, Molina Healthcare's financial guidance for fiscal year 2025 was substantially likely to be cut. The Molina Healthcare class action lawsuit further alleges that on July 7, 2025, Molina Healthcare revealed second quarter 2025 adjusted earnings of approximately $5.50 per share, which was "below its prior expectations" due to "medical cost pressures in all three lines of business." Molina Healthcare also disclosed that it "expects these medical cost pressures to continue into the second half of the year," cut guidance for expected adjusted earnings per share 10.2% at the midpoint, and that it was experiencing a "short-term earnings pressure" from a "dislocation between premium rates and medical cost trend which has recently accelerated," the complaint alleges. On this news, the price of Molina Healthcare stock fell, according to the complaint. Then, the Molina Healthcare class action lawsuit alleges that on July 23, 2025 Molina Healthcare reported its financial results for the second quarter ended June 30, 2025 and further cut its full-year 2025 earnings guidance. In doing so, Molina Healthcare revealed that "GAAP net income was $4.75 per diluted share for the second quarter of 2025, a decrease of 8% year over year" and it "now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share," the Molina Healthcare class action alleges. Molina Healthcare allegedly attributed its results and full year outlook to a "challenging medical cost trend environment," including "utilization of behavioral health, pharmacy, and inpatient and outpatient services." On this news, the price of Molina Healthcare stock fell nearly 17%, according to the complaint. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Molina Healthcare securities during the Class Period to seek appointment as lead plaintiff in the Molina Healthcare class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Molina Healthcare class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Molina Healthcare class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Molina Healthcare class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: https://www.rgrdlaw.com/services-litigation-securities-fraud.html Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Contact: Robbins Geller Rudman & Dowd LLP J.C. Sanchez, Jennifer N. Caringal 655 W. Broadway, Suite 1900, San Diego, CA 92101 800-449-4900 [email protected] SOURCE Robbins Geller Rudman & Dowd LLP |
|||||
|
2025-11-03 06:20
5mo ago
|
2025-11-03 01:11
6mo ago
|
Park Hotels & Resorts: Strong Foundation And Long-Term Upside Outweigh Near-Term Headwinds | stocknewsapi |
PK
|
|
|
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in PK over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-03 06:20
5mo ago
|
2025-11-03 01:16
6mo ago
|
Devon Energy: Profit From Cost Control And FCF Growth | stocknewsapi |
DVN
|
|
|
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 21:17
6mo ago
|
Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary | stocknewsapi |
SSNLF
|
|
|
-
Samsung Epis Holdings to be listed on Korea Exchange (KRX) on November 24, 2025Samsung Epis Holdings to focus on exploring next-generation growth drivers and optimizing business strategies for its subsidiaries ‒Samsung Bioepis and a new company under Samsung Epis HoldingsSamsung Bioepis will continue to operate its biosimilar business as a 100% owned subsidiary of Samsung Epis Holdings while the new subsidiary company under Samsung Epis Holdings will focus on developing next-generation biotechnology platforms INCHEON, Korea--(BUSINESS WIRE)--Samsung Epis Holdings Co., Ltd. today announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Samsung Biologics (KRX: 207940.KS). Samsung Epis Holdings will be listed on Korea Exchange (KRX) on November 24, 2025, after establishment of a new subsidiary company on November 14, 2025. Samsung Bioepis will continue to operate its biosimilar business as a 100% owned subsidiary of Samsung Epis Holdings. The new investment holding company will focus on discovering and securing investment opportunities in biotechnology for the company and its subsidiaries’ long-term growth, with scientific innovation remaining the source of our value creation. Share Kyung-Ah Kim will serve as the President and Chief Executive Officer (CEO) of Samsung Epis Holdings, in addition to her current role as the President and CEO of Samsung Bioepis. "The new investment holding company will focus on discovering and securing investment opportunities in biotechnology for the company and its subsidiaries’ long-term growth, with scientific innovation remaining the source of our value creation. In the meantime, Samsung Bioepis will remain committed to ensuring the continued development, manufacturing, and distribution of quality-assured biosimilar medicines to patients around the world,” said Kyung-Ah Kim, President and CEO of Samsung Epis Holdings. “By establishing an independent decision-making structure, we see the potential for further growth and investment. Progress is being made to secure next-generation therapeutic technology on the back of the capabilities accumulated through our biosimilar business. With the spin-off, we expect to have more opportunities to explore next-generation growth drivers.” Samsung Epis Holdings Co., Ltd. As an investment holdings company dedicated to biopharmaceuticals and biotechnology, Samsung Epis Holdings will optimize business strategies for its subsidiaries and maximize corporate and shareholder value through proactive R&D and investment. Samsung Epis Holdings will implement and deploy a focused growth strategy designed to ensure efficient and effective resources while reinforcing the business strategies and platforms for the two subsidiaries. The New Subsidiary Company The new subsidiary company under Samsung Epis Holdings will develop next-generation biotechnology platforms targeting various modalities to identify future growth engines beyond the biosimilar business and drive innovation. The new subsidiary will focus on transforming highly scalable core technologies into platforms and discovering diverse new drug candidates, including joint development with global pharmaceutical companies. For more information about Samsung Epis Holdings and its new subsidiary, please visit: https://www.samsungepisholdings.com/en/ Samsung Bioepis Co., Ltd. Samsung Bioepis will continue to focus on its core business, including research and development, manufacturing, supply distribution, and commercialization of biologic medicines. Since its foundation in 2012, Samsung Bioepis has developed the industry’s most rapidly advancing biosimilar medicines portfolio, with 11 biosimilars approved and available around the world. In 2024, the company achieved record-breaking sales of KRW 1.5377 trillion and operating profit of KRW 435.4 billion. Samsung Bioepis will focus on strengthening its development capabilities, with a goal of securing 20+ biosimilars in the long-term. Samsung Bioepis has already opened up access to biologic medicines across immunology, oncology, ophthalmology, hematology, and nephrology, and the company is expanding into other therapeutic areas to address unmet needs of patients. For more information about Samsung Bioepis, please visit: www.samsungbioepis.com and follow Samsung Bioepis on social media – LinkedIn, X. More News From Samsung Epis Holdings Co., Ltd. Back to Newsroom |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 21:24
6mo ago
|
Faraday Future Appoints Chris Nixon Cox as Global Strategic Advisor to Accelerate Global Expansion of “EAI + Crypto” Strategy | stocknewsapi |
FFAI
|
|
|
November 02, 2025 21:24 ET
| Source: Faraday Future Mr. Cox will strengthen global investor relations, government affairs, and industrial partnerships and will join the planned FFAI Global Strategic Advisory Council. LOS ANGELES, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced a global strategic advisory agreement with Chris Nixon Cox, Board Member of the Richard Nixon Foundation and grandson of the 37th President of the United States, Richard Nixon. Mr. Cox will serve as a senior advisor for global investor relations, government affairs, and industrial cooperation, supporting the accelerated international deployment of FF’s “EAI + Crypto” Dual-Flywheel and Dual-Bridge strategy. In this role, Mr. Cox will introduce potential global strategic investors, enhance government engagement and policy communications, and expand cross-border industrial cooperation on behalf of FF. He will also join the FFAI Global Strategic Advisory Council, which FF plans to establish. “I’m excited to take on this role with a company that is not only expanding its global automotive footprint but also pioneering in crypto and web3, marking an important turning point in FF’s development,” said Mr. Cox. “My experience in global capital markets and sustainable technologies can help drive the Company’s strategic growth at this pivotal stage.” “As we accelerate the global deployment of our ‘EAI + Crypto’ Dual-Flywheel and Dual-Bridge strategy, strengthening access to top-tier investors, government relationships, and international industrial cooperation is mission-critical,” said YT Jia, Founder and Global Co-CEO of Faraday Future. “We’re pleased to welcome Chris. His cross-sector influence and expertise in capital markets, public policy, and regulatory affairs will be highly valuable at this inflection point in FF’s international expansion and AI-driven transformation.” About Chris Nixon Cox Mr. Cox is a leader in both the public and private sectors. He serves on the Board of the Richard Nixon Foundation and is CEO of Lightswitch Capital, an investment firm primarily focused on the biotechnology sector. Previously, Mr. Cox worked at Weil, Gotshal & Manges LLP in New York, advising major private equity clients on mergers and acquisitions, and he served as New York State Executive Director for Senator John McCain’s 2008 U.S. Presidential campaign. He holds a B.A. in Politics from Princeton University, a J.D. from NYU School of Law, and a Finance Certificate from NYU Stern School of Business. He resides in New York. ABOUT FARADAY FUTURE Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company’s mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future’s flagship model, the FF91, exemplifies its vision for luxury, innovation, and performance. The FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation. Join us in shaping the future of intelligent transportation. For more information, please visit https://www.ff.com/us/ CONTACTS: Investors (English): [email protected] Investors (Chinese): [email protected] Media: [email protected] Photos accompanying this announcement are available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/1f08429b-d21b-4180-82d9-422824d500aa https://www.globenewswire.com/NewsRoom/AttachmentNg/aa12d851-4650-4dc6-86d5-d76c1268f1fe Faraday Future Appoints Chris Nixon Cox as Global Strategic Advisor to Accelerate Global Expansion o... Faraday Future Founder and Global Co-CEO YT Jia (L) Congratulates Chris Nixon Cox (R) on Becoming a ... Faraday Future Appoints Chris Nixon Cox as Global Strategic Advisor to Accelerate Global Expansion o... Faraday Future Appoints Chris Nixon Cox (front row, second from right) as Global Strategic Advisor t... https://www.ff.com/ |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 21:31
6mo ago
|
New Preferred Stock And Baby Bond IPOs, October 2025 | stocknewsapi |
DTE
TRC
|
|
|
SummaryFour new preferred stock and baby bond offerings were tracked, with yields ranging from 6.25% to 7.375%, including DTK, XELLL, TCPA, and CCID.DTK (DTE Energy) and XELLL (Xcel Energy) both achieved a perfect Compliance Score, offering 6.25% fixed coupons and investment-grade ratings.Current high-quality preferreds and ETDs (Compliance Score 10) are trading at a 2% discount to par, with an average yield of 6.62%.Investors can often buy new preferred shares at wholesale prices via OTC markets, and tracking par crosses helps identify bargains in the sector. Richard Drury/DigitalVision via Getty Images
New Offering Summaries: Of the various offerings we will summarize below, two of them, DTK and XELLL (both energy companies and both offering junior subordinated notes due 2085), achieved a perfect “Compliance Score” on our ten-point scale. Long-time readers of our Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. Recommended For You |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 21:39
6mo ago
|
Rithm Capital: 9.1% Dividend Yield, 15% Discount, I Bought The Dip | stocknewsapi |
RITM
|
|
|
Analyst’s Disclosure:I/we have a beneficial long position in the shares of RITM, ARES, OWL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 21:42
6mo ago
|
Delek US Holdings: Upside Expected As EPA Actions Are A Game-Changer | stocknewsapi |
DK
|
|
|
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 21:44
6mo ago
|
China's Baidu says it's running 250,000 robotaxis a week — same as Alphabet's Waymo did this spring | stocknewsapi |
BIDU
|
|
|
BEIJING — As Baidu ramps up its robotaxi operations worldwide, fully driverless weekly rides as of Oct. 31 have now surpassed 250,000 orders, according to a spokesperson for the company's driverless car unit Apollo Go.
That's on par with what Waymo reported in late April for its weekly paid U.S. rides. When contacted by CNBC, Waymo did not have a new specific figure to share. The Alphabet-backed robotaxi operator primarily operates in San Francisco and Los Angeles in California and Phoenix, Arizona. Waymo partners with Uber in Austin and Atlanta. The ramp up in Baidu's robotaxi capabilities comes as Chinese and U.S. companies have been competing for leadership in advanced technology, including artificial intelligence, electric cars and autonomous driving. It was not clear for how long Apollo Go has been operating 250,000 rides a week. For the quarter ended June 30, the company averaged about 169,000 rides a week based on CNBC calculations of the 2.2 million fully driverless robotaxi rides disclosed for the period. Baidu's Apollo Go primarily operates robotaxis in Wuhan and parts of Beijing, Shanghai and Shenzhen in mainland China. The company is also expanding to Hong Kong, Dubai, Abu Dhabi and, most recently, Switzerland. Robotaxis typically must undergo phases of public testing before local regulators allow companies to charge fares. Apollo Go said it has received 17 million robotaxi ride orders to date, and that its cars have driven 240 million kilometers (149 million miles), with 140 million fully driverless rides. watch now On safety, Apollo Go disclosed on average there has been one airbag deployment incident for every 10.1 million kilometers driven, but so far there's has not been any major accident involving human injury or death. Baidu is scheduled to next release its quarterly results on Nov. 18 before U.S. market open. The company is set to hold its annual tech conference in Beijing on Nov. 13. Weekly robotaxi figures from Chinese rivals Pony.ai and WeRide were not immediately available. Waymo did not immediately respond to a request for an update to the figures shared in April. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 21:53
6mo ago
|
JBBB: Sell It If You Want To Keep Your Shirt (Rating Downgrade) | stocknewsapi |
JBBB
|
|
|
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 22:01
6mo ago
|
Cardinal Health CEO says Obamacare subsidies extension under review 'every single day' | stocknewsapi |
CAH
|
|
|
Cardinal Health CEO Jason Hollar discusses medication affordability, the Obamacare subsidies battle and more on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusiness #healthcare #medicine #pharma #affordability #obamacare #insurance #subsidies #economy #business #finance #medical #drugs #hospitals #patients #policy #government #health #usnews #governmentshutdown
|
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 22:24
6mo ago
|
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit | stocknewsapi |
SVRA
|
|
|
, /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the "Class Period"), of the important November 7, 2025 lead plaintiff deadline. So what: If you purchased Savara securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Savara class action, go to https://rosenlegal.com/submit-form/?case_id=44874 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) the MOLBREEVI (a clinical trial for the treatment of a rare lung disease) Biologics License Application ("BLA") lacked sufficient information regarding MOLBREEVI's chemistry, manufacturing, and/or controls; (2) accordingly, the FDA was unlikely to approve the MOLBREEVI BLA in its current form; (3) the foregoing made it unlikely that Savara would complete submission of the MOLBREEVI BLA within the timeframe that Savara had represented to investors; (4) the delay in MOLBREEVI's regulatory approval increased the likelihood that Savara would need to raise additional capital; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Savara class action, go to https://rosenlegal.com/submit-form/?case_id=44874 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com SOURCE THE ROSEN LAW FIRM, P. A. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 22:26
6mo ago
|
VFC Investors have Opportunity to Lead V.F. Corporation Securities Fraud Lawsuit | stocknewsapi |
VFC
|
|
|
, /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of V.F. Corporation (NYSE: VFC) between October 30, 2023 and May 20, 2025, both dates inclusive (the "Class Period"), of the important November 12, 2025 lead plaintiff deadline. So what: If you purchased V.F. Corporation securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the V.F. Corporation class action, go to https://rosenlegal.com/submit-form/?case_id=44811 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 12, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, defendants disseminated materially false and misleading statements and/or concealed material adverse facts concerning the true state of V.F. Corporation's turnaround plans. Specifically, defendants provided investors with material information concerning V.F. Corporation's turnaround plan ("Reinvent"), which in part focused on efforts to return the Vans brand to positive growth. The lawsuit alleges that defendants concealed that additional significant reset actions would be necessary to return the Vans brand to growth, and would result in significant setbacks to Vans' revenue growth trajectory. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the V.F. Corporation class action, go to https://rosenlegal.com/submit-form/?case_id=44811 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com SOURCE THE ROSEN LAW FIRM, P.A. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 23:12
6mo ago
|
Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer | stocknewsapi |
AKESF
|
|
|
, /PRNewswire/ -- Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative breast cancer (TNBC) has been granted Breakthrough Therapy Designation (BTD) by the Center for Drug Evaluation (CDE) from China's National Medical Products Administration (NMPA).
The Phase III multicenter, randomized, double-blind clinical trial (HARMONi-BC1/AK112-308) for this combination therapy is ongoing in China. The BTD designation is expected to further expedite the clinical development and regulatory approval process of ivonescimab for the treatment of TNBC. This marks the fourth BTD granted by the CDE for ivonescimab. The previous three designations include: Ivonescimab combined with chemotherapy for locally advanced or metastatic NSCLC resistant to EGFR-TKI therapy, which has now been approved for marketing in China and added to China's National Reimbursement Drug List. First-line treatment of PD-L1-positive locally advanced or metastatic NSCLC, which has also been approved for marketing in China. Ivonescimab combined with docetaxel for locally advanced or metastatic NSCLC patients who have failed previous PD-1/L1 inhibitors and platinum-based chemotherapy. The Phase III clinical trial for this indication in China is currently ongoing. Receiving four Breakthrough Therapy Designations affirms ivonescimab's substantial clinical benefit across multiple major cancer types and reinforces Akeso's commitment to addressing critical unmet medical needs. The therapy is currently advancing in 14 Phase III clinical trials worldwide, including four international multicenter studies. These large pivotal studies, backed by repeated regulatory recognition, position ivonescimab to deliver transformative, life-saving outcomes for patients worldwide. Forward-Looking Statement of Akeso, Inc. This announcement by Akeso, Inc. (9926.HK, "Akeso") contains "forward-looking statements". These statements reflect the current beliefs and expectations of Akeso's management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso's other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law. About 依达方 ® (PD-1/VEGF Bispecific, Ivonescimab) Ivonescimab is a first-in-class, PD-1/VEGF bispecific immuno-oncology agent developed by Akeso. In May 2024, it received approval from the China National Medical Products Administration (NMPA) for the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC) after EGFR-TKI therapy. This approval made ivonescimab the world's first bispecific antibody based on a synergistic "immunotherapy plus anti-angiogenesis" mechanism. In November 2024, ivonescimab was also included in China's National Reimbursement Drug List (NRDL). Additionally, ivonescimab has been approved as a first-line treatment for advanced NSCLC with positive PD-L1 expression. In the Phase III HARMONi-2 study, ivonescimab demonstrated superior efficacy compared to pembrolizumab, resulting in significantly improved clinical outcomes. In 2025, the final overall survival (OS) analysis from the HARMONi-A study showed that ivonescimab met the OS endpoint, providing clinically meaningful and statistically significant OS benefits. As the first final OS analysis in a Phase III trial of ivonescimab, these results reaffirm the agent's groundbreaking value in both progression-free survival (PFS) and overall survival for patients. Moreover, a head-to-head Phase III trial comparing ivonescimab plus chemotherapy to tislelizumab plus chemotherapy in first-line treatment for squamous NSCLC also yielded promising results. These findings position ivonescimab as a substantial clinical breakthrough whether in comparison to PD-1 monotherapy in immuno-oncology, the current standard of care (SOC) of PD-1 inhibitors combined with chemotherapy, or VEGF-targeted therapies in the anti-angiogenesis field. This underscores ivonescimab's significant potential in cancer treatment. As ivonescimab continues to demonstrate substantial clinical value and the potential to redefine treatment standards, its presence in key immuno-oncology indications is expanding rapidly. In lung cancer, the most prevalent cancer globally, ivonescimab is currently involved in 8 registrational/Phase III clinical studies, including: First-line NSCLC (squamous and non-squamous, compared to pembrolizumab + chemotherapy, international multicenter) First-line squamous NSCLC (compared to tislelizumab + chemotherapy) NSCLC after EGFR-TKI progression (HARMONi-A and HARMONi) First-line PD-L1-positive NSCLC (compared to pembrolizumab) First-line PD-L1-highly expressed NSCLC (compared to pembrolizumab) IO-resistant NSCLC Consolidation therapy for limited-stage small cell lung cancer post-concurrent chemoradiotherapy In other major tumor types, ivonescimab is rapidly advancing first-line indications with ongoing Phase III trials in: First-line biliary tract cancer (compared to durvalumab + chemotherapy) First-line PD-L1–positive head and neck squamous cell carcinoma in combination with ligufalimab (CD47) (compared to pembrolizumab) In the challenging area of cold tumors, ivonescimab has received its fourth Breakthrough Therapy Designation for first-line triple-negative breast cancer. Additionally, Phase III studies are underway for first-line MSS/pMMR colorectal cancer (which accounts for 95% of CRC cases) and first-line pancreatic cancer. Further Phase III studies are also being prepared. With nearly 20 Phase II studies across more than 10 additional indications, ivonescimab has established a robust data foundation to support the rapid global expansion of Phase III trials. About Akeso Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world's first or best-in-class innovative biological medicines. Founded in 2012, the company has created a unique integrated R&D innovation system with the comprehensive end-to-end drug development platform (ACE Platform) and bi-specific antibody drug development technology (Tetrabody) as the core, a GMP-compliant manufacturing system and a commercialization system with an advanced operation mode, and has gradually developed into a globally competitive biopharmaceutical company focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 24 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise. For more information, please visit https://www.akesobio.com/en/about-us/corporate-profile/ and follow us on Linkedin. SOURCE Akeso, Inc. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 23:16
6mo ago
|
BYD stock price has crashed as sales tumble: time to buy the dip? | stocknewsapi |
BYDDF
|
|
|
The BYD stock price continued its freefall on Monday, moving to its lowest level in over nine months after the company published weak delivery data. It dropped to a low of H$98.5, down by 28% from its highest point in May this year.
|
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 23:18
6mo ago
|
BOIL: Enhanced Natural Gas Exposure With Positive Outlook | stocknewsapi |
BOIL
|
|
|
Analyst’s Disclosure:I/we have a beneficial long position in the shares of GEV, EQT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 23:35
6mo ago
|
Linear Minerals Corp. Announces Exploration Results from Lac Marion Property, Québec | stocknewsapi |
LINMF
|
|
|
VANCOUVER, BC / ACCESS Newswire / November 2, 2025 / Linear Minerals Corp. (CSE:LINE)(OTC:LINMF)(WKN:A2J C89) ("Linear" or the "Company") is pleased to announce the results of its initial exploration program at the Lac Marion Uranium and Rare Earth Element (REE) Property (the "Property"), located near Mont Laurier in the Laurentides region of southwestern Québec. The program included geological mapping, prospecting, radiometric surveys, and rock sampling across the 2,760-hectare land package.
|
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 23:38
6mo ago
|
Carriage Services Is Coming Back To Life | stocknewsapi |
CSV
|
|
|
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-02 23:41
6mo ago
|
Sable Offshore Corp. to Host Conference Call to Provide a Strategic Update to Investors | stocknewsapi |
SOC
|
|
|
HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. to Host Conference Call to Provide a Strategic Update to Investors.
|
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-03 00:00
6mo ago
|
Ensurge Micropower ASA – Joint development and investment agreements with Corning Incorporated to advance solid-state microbattery technology | stocknewsapi |
ENMPY
|
|
|
November 03, 2025 00:00 ET
| Source: Ensurge Micropower ASA Oslo, Norway, 3 November 2025 Ensurge Micropower ASA ("Ensurge" or the "Company") today announces that the Company has entered into a set of agreements with Corning Incorporated (“Corning”), one of the world’s leading innovators in glass, ceramics, and materials science, to jointly develop ultra-high performance solid-state microbatteries based on Ensurge’s platform. Ensurge and Corning have entered into a joint development agreement to establish a framework and joint development program for the two companies to collaborate to integrate Corning's ribbon ceramic materials and process technology with Ensurge's proven solid-state microbattery architecture (the “Joint Development Agreement”). Together, Ensurge and Corning aim to deliver an ultra-high energy density product line extension to commercialize batteries that power high-volume consumer, medical, industrial, and defense applications. Corning’s contribution includes process and manufacturing excellence, alongside deep materials science expertise. Pairing this competence with Ensurge’s solid-state microbattery platform strengthens Ensurge’s path to scale, including improved execution confidence, greater assurance in commercialization, and a stronger foundation for long‑term growth. Further, Ensurge and Corning have entered into an investment agreement that regulates the terms for investments by Corning in the Company (the “Investment Agreement”). Under the terms of the Joint Development Agreement and Investment Agreement (together, the “Agreements”), Corning shall provide certain engineering and other Corning resources to Ensurge, the costs of which shall be convertible into new shares in Ensurge, by set-off of the accounts receivable held by Corning for the services performed. Following the end of each quarter, such costs shall be converted to shares in Ensurge (the “Conversion Shares”) at a pre-determined price of NOK 1.11 per share (“Conversion Price”), which is calculated based on the average closing price of the Company’s shares over the 10 last trading days prior to the execution of the Agreements. The maximum monetary amount that may be converted to Conversion Shares, by set-off, is USD 5 million. Ensurge shall further issue certain warrants to Corning, on the terms of which Corning shall have the option to invest up to USD 10 million in the Company by exercise of such warrants (the “Warrants”). Each Warrant shall have an exercise price of NOK 1.50 per share (the “Exercise Price”). The Warrants may be exercised in the two-year period following date of approval by an extraordinary general meeting (the “EGM”), subject, however, to the Joint Development Agreement or a subsequent commercial agreement between Ensurge and Corning remaining in effect. The Warrants will be granted for no charge. The Warrants will be registered in the VPS but will not be admitted to trading on Euronext Oslo Børs. The issue of Warrants and the authorization to issue Conversion Shares remain subject to approval by the EGM, which Ensurge will convene shortly. The Company hereby invites investors, analysts, and other stakeholders to a webcast presentation hosted by Arctic Securities AS today at 14:00am CET (08:00am ET). Please use the following link to access the webcast: https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZGEzYTdmZDgtZTk4Ni00ZDA4LWE1MDEtNTkwMDRiOTgwZGJl%40thread.v2/0?context=%7b%22Tid%22%3a%22d02701f9-3b23-4b3f-8fce-29ed54632bf8%22%2c%22Oid%22%3a%2249eee719-db83-4ef4-aca0-334090732543%22%7d About Ensurge Micropower: Ensurge (www.ensurge.com) powers the future of AI-enabled devices with advanced microbattery technology that delivers unmatched performance and safety. From its base in San Jose, California, the Company's team of battery specialists have pioneered thin-film batteries produced on high-precision roll-to-roll production processes. These innovations enable new possibilities in form-factor-constrained applications across consumer, medical, and industrial markets. Ensurge partners with leading global customers to accelerate their products to market and is listed on the Oslo Stock Exchange. For more news and information on Ensurge, please visit https://www.ensurge.com/news-room. For more information, please contact: Shauna McIntyre - Chief Executive Officer E- mail: [email protected]. This information is considered to be inside information pursuant to the EU Market Abuse Regulation (MAR) and is subject to the disclosure requirements pursuant to MAR article 17 and section 5 -12 of the Norwegian Securities Trading Act. This stock exchange release was published by Ståle Bjørnstad, VP, Corporate Development and IR, on 3 November 2025 at 06:00 CEST. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-03 00:01
6mo ago
|
DNOW Announces Third Quarter 2025 Earnings Conference Call | stocknewsapi |
DNOW
|
|
|
HOUSTON--(BUSINESS WIRE)--DNOW Inc. (NYSE: DNOW) has scheduled a conference call to discuss the results for the third quarter of 2025 on Wednesday, November 5, 2025, at 8:00 am (US Central Time). Financial results for the third quarter ending September 30, 2025, are expected to be released that morning before the market opens.
The call will be broadcast through the Investor Relations link on DNOW’s web site at ir.dnow.com on a listen-only basis. Listeners should log in prior to the start of the call to register for the webcast. A replay of the call will be available online for thirty days following the conference. Participants may also join the conference call by dialing 1-888-660-6431 within North America or 1-929-203-2118 outside of North America, Access Code: 7372055, fifteen minutes prior to the scheduled start time and asking for the “DNOW Earnings Conference Call.” DNOW is a supplier of energy and industrial products and packaged, engineered process and production equipment with a legacy of over 160 years. Headquartered in Houston, Texas, with approximately 2,500 employees and a network of locations, we offer a broad set of supply chain solutions combined with a suite of digital offerings branded as DigitalNOW® that provide customers access to highly complementary digital commerce, data and information management channels. Our locations provide products and solutions to exploration and production, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction as well as companies operating in the decarbonization, energy evolution and renewables end markets. More News From DNOW Inc. |
|||||
|
2025-11-03 05:20
5mo ago
|
2025-11-03 00:01
6mo ago
|
Ensurge and Corning announce collaboration to advance solid-state microbattery technology | stocknewsapi |
ENMPY
|
|
|
November 03, 2025 00:01 ET
| Source: Ensurge Micropower ASA Joint Development Agreement will establish a foundation for ultra-high energy density microbatteries San Jose, California, United States - Ensurge (OSE: ENSU), a global leader in solid-state microbattery technology, and Corning Incorporated (NYSE: GLW), one of the world’s leading innovators in glass, ceramics, and materials science, today announced a set of agreements to jointly develop Ensurge’s ultra-high performance solid-state microbatteries. The agreements establish a framework for the two companies to integrate Corning's Ribbon Ceramic materials and process technology with Ensurge's proven solid-state microbattery architecture. Together, the two companies aim to deliver an ultra-high energy density product line extension to commercialize batteries that power high-volume consumer, medical, industrial, and defense applications. “Ensurge and Corning share a drive for excellence in innovation and manufacturing,” said Ron Verkleeren, Senior Vice President, Corning Emerging Innovations Group. “We’re looking forward to collaborating with Ensurge to help advance microbattery technology.” "Collaborating with an industry pioneer like Corning represents an important strategic milestone for Ensurge,” said Shauna McIntyre, CEO of Ensurge. "Together, we’re applying Corning's materials science leadership to Ensurge’s solid-state microbattery platform, creating a foundation for transformative advances that will power the next generation of smart devices.” About Ensurge Ensurge (www.ensurge.com) powers the future of AI-enabled devices with advanced microbattery technology that delivers unmatched performance and safety. From its base in San Jose, California, the company has built a world-class team of specialists and pioneered thin-film batteries produced on high-precision roll-to-roll production lines. These innovations enable new possibilities in form-factor-constrained applications across consumer, medical, and industrial markets. Ensurge partners with leading global customers to accelerate their AI-driven products to market and is listed on the Oslo Stock Exchange. About Corning Incorporated Corning (www.corning.com) is one of the world’s leading innovators in materials science, with a 170-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramic science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people's lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries. Corning's capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping our customers capture new opportunities in dynamic industries. Today, Corning's markets include optical communications, mobile consumer electronics, display, automotive, solar, semiconductors, and life sciences. |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 21:15
6mo ago
|
LINK Price Slides to $16.60 as Fed Rate Cut Fails to Boost Risk Assets Amid Technical Deterioration | cryptonews |
LINK
|
|
|
Zach Anderson
Nov 03, 2025 03:15 Chainlink drops 3% to $16.60 as Federal Reserve's 25bp rate cut triggers crypto selloff, with LINK testing critical support near $16.37 Bollinger Band lower boundary. Quick Take • LINK trading at $16.60 (down 3.0% in 24h) • Federal Reserve rate cut paradoxically weakens crypto markets including Chainlink • LINK testing lower Bollinger Band support at $16.37 • Following Bitcoin's volatile response to monetary policy shift Market Events Driving Chainlink Price Movement The Federal Reserve's 25 basis point interest rate cut on October 29th has created unexpected headwinds for LINK price, contrary to traditional market expectations. While rate cuts typically benefit risk assets, the cryptocurrency market has responded negatively, with Bitcoin experiencing significant volatility between $115,960 and $106,950 since the announcement. This monetary policy shift has coincided with analysts predicting a potential 15% decline in LINK's value due to deteriorating technical indicators and challenging macroeconomic conditions. The combination of Federal Reserve uncertainty and bearish technical signals has created a perfect storm for Chainlink price weakness. The absence of significant positive catalysts in Chainlink's ecosystem over the past week has left LINK price vulnerable to broader market forces, with institutional traders appearing to reduce risk exposure across cryptocurrency positions. LINK Technical Analysis: Testing Critical Support Zone Price Action Context Chainlink technical analysis reveals concerning momentum as LINK price trades below all major moving averages except the 200-day SMA at $17.96. The current $16.60 level represents a significant 17% decline from the 50-day moving average at $20.04, indicating sustained selling pressure. LINK price is closely following Bitcoin's bearish trajectory, showing high correlation with the broader crypto market's response to Federal Reserve policy uncertainty. Trading volume on Binance spot market reached $49.5 million, suggesting institutional participation in the selloff. Key Technical Indicators The RSI at 39.60 has entered oversold territory, typically indicating potential bounce conditions, though momentum remains weak. The MACD histogram shows a slight bullish divergence at 0.0659, but the main MACD line remains deeply negative at -0.7824. Chainlink's position at 0.0977 on the Bollinger Band %B indicator places LINK price dangerously close to the lower band at $16.37, suggesting potential capitulation if this support fails. Critical Price Levels for Chainlink Traders Immediate Levels (24-48 hours) • Resistance: $17.56 (20-day SMA and Bollinger Band middle) • Support: $16.37 (Bollinger Band lower boundary) Breakout/Breakdown Scenarios A break below $16.37 could trigger cascade selling toward the immediate support at $15.69, with the strong support zone at $7.90 representing a worst-case scenario. Conversely, reclaiming $17.56 would signal potential stabilization and target the immediate resistance at $19.26. LINK Correlation Analysis • Bitcoin: LINK price showing 85%+ correlation with BTC's volatile response to Fed policy • Traditional markets: Following risk-off sentiment despite typically positive rate cut implications • Sector peers: Underperforming relative to other oracle tokens due to technical weakness Trading Outlook: Chainlink Near-Term Prospects Bullish Case A successful defense of $16.37 support combined with Bitcoin stabilization above $110,000 could trigger a relief rally toward $19.26. Chainlink technical analysis suggests oversold conditions may attract value buyers if broader market sentiment improves. Bearish Case Failure to hold Bollinger Band support at $16.37 would likely accelerate selling toward $15.69, with LINK price potentially testing yearly lows if macroeconomic uncertainty persists. The 15% decline prediction from analysts could materialize if current technical deterioration continues. Risk Management Conservative traders should consider stop-losses below $16.00 given the proximity to critical support. Position sizing should account for the elevated ATR of $1.34, indicating above-average volatility conditions for LINK price movements. Image source: Shutterstock link price analysis link price prediction |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 21:21
6mo ago
|
UNI Plunges to Lower Bollinger Band After Security Exploit Sparks $15M Trading Volume Surge | cryptonews |
UNI
|
|
|
Iris Coleman
Nov 03, 2025 03:21 Uniswap drops 4.1% to $5.60 following security exploit concerns affecting V3 functions, testing critical support as Bitcoin correlation intensifies market selloff. Quick Take • UNI trading at $5.60 (down 4.1% in 24h) • Security exploit concerns targeting V3 functions drive significant outflows • Price testing lower Bollinger Band support at $5.62 • Following Bitcoin's decline below $111,000 amid broader crypto weakness Market Events Driving Uniswap Price Movement The primary catalyst behind UNI price weakness stems from security exploit concerns that emerged on October 30, 2025, specifically targeting Uniswap's V3 functionality. This security incident prompted significant market outflows as investors grew anxious about the platform's vulnerability, directly impacting trader confidence in the protocol's safety measures. The exploit concerns forced Uniswap to initiate comprehensive reviews of its security and audit procedures, signaling the seriousness of the situation. Market participants responded swiftly, with trading volume surging to $15.8 million on Binance spot markets as investors repositioned their holdings. Compounding UNI's decline, Bitcoin's drop below $111,000 during the same period created additional downward pressure across the cryptocurrency sector. The broader market selloff was attributed to escalating U.S.-China trade tensions, which drove investors toward traditional safe-haven assets like gold, further reducing appetite for risk assets including altcoins. UNI Technical Analysis: Testing Critical Support Zone Price Action Context UNI price action reveals significant technical deterioration, with the token trading below all major moving averages. The current price of $5.60 sits substantially below the 20-day SMA at $6.17 and even further from the 50-day SMA at $7.27, indicating sustained bearish momentum. The Bollinger Band position shows UNI at -0.0199 %B, placing it virtually at the lower band support of $5.62. This positioning suggests the token is potentially oversold in the near term, though downside momentum remains strong given the security concerns. Key Technical Indicators The RSI reading of 34.28 indicates UNI has moved into oversold territory without reaching extreme levels, suggesting further downside remains possible. However, the MACD histogram shows a slight bullish divergence at 0.0118, indicating selling pressure may be beginning to moderate. Stochastic indicators present a mixed picture, with %K at 1.46 showing extreme oversold conditions while %D at 13.50 suggests some stabilization potential. The daily ATR of $0.48 reflects elevated volatility, providing both risk and opportunity for active traders. Critical Price Levels for Uniswap Traders Immediate Levels (24-48 hours) • Resistance: $5.94 (7-day SMA and recent high) • Support: $5.58 (24-hour low and immediate technical floor) Breakout/Breakdown Scenarios A break below $5.58 support could trigger accelerated selling toward the $5.00 psychological level, with strong support not appearing until the $4.78 52-week low. Conversely, a recovery above $5.94 would need to be sustained to challenge the $6.17 20-day moving average, where more substantial resistance awaits. UNI Correlation Analysis Bitcoin correlation has intensified during this selloff, with UNI following the broader cryptocurrency market lower as Bitcoin tested support near $110,000. This correlation suggests UNI price recovery will likely require Bitcoin to stabilize and begin recovering. Traditional market impacts appear secondary, though the flight to gold amid trade tensions has reduced overall risk appetite, indirectly pressuring cryptocurrency valuations including Uniswap. Trading Outlook: Uniswap Near-Term Prospects Bullish Case Recovery requires resolution of security concerns through successful audits and enhanced security measures. Technical bounce potential exists from current oversold levels, particularly if Bitcoin finds support. Target resistance levels include $5.94 initially, followed by $6.17 if momentum builds. Bearish Case Continued security uncertainties could drive additional outflows, with Bitcoin weakness providing additional downside pressure. Key risk levels include a break below $5.58 immediate support, which could accelerate selling toward $5.00 and potentially the $4.78 yearly low. Risk Management Traders should consider tight stop-losses below $5.50 given the security overhang, while position sizing should account for elevated volatility. Any recovery trades require confirmation above $5.94 to signal potential trend reversal from current oversold conditions. Image source: Shutterstock uni price analysis uni price prediction |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 21:27
6mo ago
|
BCH Price Analysis - November 03, 2025 | cryptonews |
BCH
|
|
|
Caroline Bishop
Nov 03, 2025 03:27 BCH price trades at $528.90 after declining 4.2% in 24 hours as Federal Reserve's hawkish commentary on future rate cuts creates uncertainty across cryptocurrency markets. Quick Take • BCH trading at $528.90 (down 4.2% in 24h) • Federal Reserve's hawkish stance on December rate cuts pressuring crypto markets • Bitcoin Cash testing support near $522.90 daily low • Broader risk-off sentiment affecting correlation with traditional markets Market Events Driving Bitcoin Cash Price Movement The Federal Reserve's 25 basis point rate cut on October 29th initially provided relief to risk assets, but Chair Jerome Powell's subsequent hawkish commentary has since weighed on cryptocurrency markets. Powell's statement that a December rate cut is "not a foregone conclusion" introduced fresh uncertainty, prompting investors to reassess their positions in risk assets including Bitcoin Cash. This macro headwind has overshadowed the positive technical developments for Bitcoin Cash, including protocol upgrades that enhanced smart contract capabilities and a notable 45.8% increase in trading volume that helped BCH price recover from October's $500 low. The BCH price briefly tested the $570-571 resistance zone before retreating to current levels. U.S.-China trade progress announced during President Trump's Seoul visit provided some offsetting positive sentiment, but the Federal Reserve's hawkish pivot has dominated market psychology across risk assets. Bitcoin Cash technical analysis shows the cryptocurrency remains vulnerable to broader macro sentiment shifts affecting the entire digital asset sector. BCH Technical Analysis: Consolidation Below Key Resistance Price Action Context Bitcoin Cash currently trades below its 7-day moving average of $544.19 but maintains position above the critical 200-day SMA at $500.06. The BCH price action reflects the broader cryptocurrency market's struggle with macro uncertainty, as institutional flows remain sensitive to Federal Reserve policy signals. Trading volume of $32.5 million on Binance spot markets indicates moderate institutional interest despite the pullback. Bitcoin Cash has diverged slightly from Bitcoin's performance today, showing relatively more resilience in the face of selling pressure. This suggests some underlying strength in BCH fundamentals, particularly following recent protocol improvements. Key Technical Indicators The daily RSI reading of 48.67 places Bitcoin Cash in neutral territory, providing room for movement in either direction. The MACD histogram shows a bullish reading of 4.8672, indicating underlying momentum remains positive despite today's price decline. Bitcoin Cash's position within the Bollinger Bands at 0.6095 suggests the cryptocurrency is trading in the upper portion of its recent range, though still below the upper band resistance at $580.87. The daily ATR of $31.18 indicates elevated volatility typical of the current market environment. Critical Price Levels for Bitcoin Cash Traders Immediate Levels (24-48 hours) • Resistance: $554.00 (24-hour high and short-term rebound level) • Support: $522.90 (today's low and critical near-term floor) Breakout/Breakdown Scenarios A break below $522.90 could expose the $500 psychological level, which coincides with the 200-day moving average. Sustained weakness below this zone would target the $443.20 strong support level. Conversely, a reclaim of $554 resistance could set up another test of the $570-571 zone, where previous rallies have stalled. A clean break above $580 would target the $624.40 52-week high. BCH Correlation Analysis Bitcoin Cash is following the broader cryptocurrency market lower today, though showing slightly better relative performance than Bitcoin. Traditional market correlations have strengthened as Federal Reserve policy uncertainty affects risk asset allocation across sectors. The S&P 500's reaction to Fed commentary is influencing crypto market sentiment, with Bitcoin Cash technical analysis showing increased sensitivity to macro factors. Gold's performance as a traditional safe haven is drawing some capital away from alternative stores of value including cryptocurrencies. Trading Outlook: Bitcoin Cash Near-Term Prospects Bullish Case A successful hold above $522.90 support combined with any dovish shift in Federal Reserve rhetoric could trigger a relief rally toward $554-570 resistance. Protocol upgrade momentum and increasing smart contract adoption provide fundamental support for higher BCH price levels. Bearish Case Continued Federal Reserve hawkishness or broader market risk-off sentiment could pressure BCH price below $522.90, potentially targeting the $500 psychological support zone. Failure to hold the 200-day moving average would signal deeper corrective action. Risk Management Conservative traders should consider stops below $520 to limit downside exposure. Given the current ATR of $31.18, position sizing should account for potential daily moves exceeding 5-6% in either direction as macro uncertainty persists. Image source: Shutterstock bch price analysis bch price prediction |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 21:33
6mo ago
|
OKX Lists KITE (Kite AI) for Spot Trading and Converts Futures to Perpetual Contracts | cryptonews |
KITE
|
|
|
Darius Baruo
Nov 03, 2025 03:33 OKX announces the listing of KITE (Kite AI) for spot trading and conversion of pre-market futures to standard perpetual futures, enhancing trading flexibility. In a significant update for cryptocurrency traders, OKX has announced the listing of KITE (Kite AI) for spot trading, alongside the conversion of pre-market futures to standard perpetual futures. This development is set to enhance the trading experience for users on the platform, allowing for more flexible and stable investment opportunities. Key Details of the KITE ListingAccording to OKX, the deposit function for KITE will be available from 3:00 am UTC on November 3, 2025. Following this, a call auction is scheduled from 12:00 pm to 1:00 pm UTC, with the KITE/USDT spot trading opening at 1:00 pm UTC. The conversion of KITE pre-market futures to standard perpetual futures is expected to occur within three hours after the spot trading commences, contingent upon the stability of the index during this period. Withdrawals for KITE will open at 4:00 pm UTC the same day. Understanding Kite AIKite AI is recognized as the first Layer 1 blockchain designed specifically for the "agentic internet." It facilitates AI agents in transacting, collaborating, and settling on-chain with verifiable identity, programmable rules, and secure transactions. This innovative approach positions Kite AI as a pioneering force in the blockchain space. Spot Market Regulations and Safety MeasuresTo ensure market stability during the initial trading phase, OKX will implement specific restrictions for the first five minutes after trading begins. These include a prohibition on market orders, a maximum limit order amount of $10,000, and a maximum net position per user of $10,000. These restrictions will be lifted five minutes after the trading start. Price limit rules will also be applied, initially using closing price-based limits until a stable index price is available, after which index-based limits will be enforced. Call Auction MechanismOKX will utilize a call auction mechanism for the KITE/USDT spot listing. This mechanism allows traders to submit buy and sell orders at their desired prices before the trading pair officially begins trading. The platform processes these submissions based on call auction rules to determine an indicative opening price. Conversion to Standard Perpetual FuturesThe transformation of KITE pre-market futures to standard perpetual futures will occur within three hours post the spot trading launch. This conversion will be seamless and will apply across web, app, and API interfaces, ensuring a consistent experience for all traders. OKX has detailed the characteristics of these perpetual futures, including the underlying KITE/USDT index, settlement in USDT, and a leverage range of 0.01-20x. The platform also outlines tiered position limits to manage risk effectively. For further information on the listing and trading mechanisms, interested parties can visit the official OKX website. Image source: Shutterstock okx kite cryptocurrency spot trading |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 22:12
6mo ago
|
Can Digitap Outperform Ethereum and Solana With 500% Gains in 2025? | cryptonews |
ETH
SOL
|
|
|
While major cryptocurrencies like Ethereum (ETH) and Solana (SOL) continue to dominate the market, a new contender, Digitap ($TAP), is drawing attention for its explosive early growth. With early buyers already seeing over 114% returns, some analysts believe Digitap could outperform both ETH and SOL by as much as 500% in 2025.
|
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 22:57
6mo ago
|
Ripple News: First Spot XRP ETF Could Go Live in Two Weeks, Says NovaDius President | cryptonews |
XRP
|
|
|
The long-awaited XRP spot exchange-traded funds (ETFs) appear to be closer than ever. Despite minor procedural delays, NovaDius President and ETF analyst Nate Geraci has now revealed that he expects the first spot XRP ETFs to launch within the next two weeks.
XRP ETF Nears Breakthrough After Years of Legal BattlesFor years, XRP’s path to a regulated ETF has been clouded by the U.S. Securities and Exchange Commission’s (SEC) litigation against Ripple. The case, which lasted five years, finally ended three months ago, clearing the biggest regulatory obstacle to an XRP ETF. Sometime in next two weeks, I expect launch of first spot xrp ETFs… SEC had open litigation against Ripple for past five years, up until three months ago. IMO, launch of spot xrp ETFs represents final nail in coffin of previous anti-crypto regulators. Have come a *LONG* way. — Nate Geraci (@NateGeraci) November 3, 2025 According to Geraci, the arrival of a spot XRP ETF would symbolize the final nail in the coffin for the anti-crypto stance once dominant within U.S. regulation. He said that the market has come a long way since the early crackdown era, and a successful XRP ETF launch could mark a new phase of acceptance for digital assets on Wall Street. Canary Capital Updates Its S-1 FilingAmid this, Canary Capital recently updated its S-1 filing for the Spot XRP ETF, revealing a crucial detail: the removal of the SEC’s delay clause. Under Section 8(a) of the Securities Act, this change allows the ETF to automatically go effective without needing formal SEC approval. Analysts interpret this as a green light for a potential Nasdaq debut on November 13. If approved, this would be the first-ever pure spot XRP ETF, giving institutional investors direct exposure to XRP’s market price similar to the structure used by spot Bitcoin and Ethereum ETFs. Analysts Expect Massive InflowsExperts expect massive inflows once the XRP ETF goes live. Early projections hint that over $1 billion in institutional capital could enter the market within the first few weeks. This outlook draws on the recent success of the Solana (SOL) spot ETFs, which attracted $417 million in their first week, outperforming several competing crypto funds. XRP, which has consistently recorded higher trading volume and open interest than Solana, could see even greater demand. Market Reaction and Short-Term VolatilityAnalysts have warned of a buy the rumor, sell the news pattern. When spot Bitcoin and Ethereum ETFs went live, both assets experienced short-term pullbacks following strong pre-launch rallies. A similar pattern may happen for XRP, especially as the broader crypto market navigates uncertainty from the ongoing U.S. government shutdown and the Federal Reserve’s next rate decision. Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors. Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices. Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners. |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 23:00
6mo ago
|
Can Bitcoin rescue Cardano's DeFi plans? Hoskinson bets on | cryptonews |
ADA
BTC
|
|
|
Journalist
Posted: November 3, 2025 Key Takeaways What’s really holding Cardano back in DeFi? Weak coordination and governance. Hoskinson noted that most of ADA’s 1.3 million active users aren’t yet fueling DeFi liquidity. How does Cardano plan to fix it? By linking with Bitcoin and real-world lending to draw new liquidity and break its DeFi stagnation loop. Cardano’s [ADA] DeFi problem is coordination. Charles Hoskinson said Cardano’s technology isn’t the issue — its challenge lies in how the community coordinates compared to Ethereum [ETH] or Solana [SOL]. Instead of chasing the usual TVL race, he’s now pushing a different path: linking Cardano with Bitcoin [BTC], and using real-world lending to pull in liquidity. Cardano is still far behind in DeFi volume, but the base is there. Now, can it unlock that user base and come back to life? What’s Cardano’s real problem? Hoskinson’s latest comments made one thing clear that the low DeFi numbers don’t reflect the size of Cardano’s actual base. He stressed that Cardano already has over 1.3 million users staking ADA and participating in governance, but most of them don’t engage in DeFi protocols. Source: IOHK_Charles/X That creates a “chicken and egg” loop where low on-chain activity keeps liquidity and partners away. As Hoskinson put it, “It’s not a technology problem. It’s not a node problem. It’s not a problem of imagination and creativity. It’s not a problem of execution. We can pretty much do anything. It’s a problem of governance and coordination and ultimately accountability and responsibility.” As far as solutions go, he referenced Midnight and RealFi as core pillars, both designed to link ADA with Bitcoin and real-world lending. This would mean capital can flow in from outside crypto. Hoskinson added that this could unlock “billions of dollars,”, especially once ADA and BTC can be lent, converted into stablecoins, and used inside real credit markets. TVL may be dwarfed, but Cardano is still building Source: DeFiLlama At press time, Cardano’s DeFi TVL sat at just $271 million, miles behind Ethereum’s $85.5 billion and Solana’s $11.29 billion. On paper, that placed ADA far behind. Yet, Santiment data showed Cardano’s Development Activity index surpassed ETH and SOL in late October, proving consistent builder momentum. Source: Santiment This is the contradiction Hoskinson was trying to explain: Cardano doesn’t have a demand problem, it has an activation problem. ADA is on weak momentum At press time, ADA traded around $0.60 and the trend remained soft. The price stayed under all major EMAs, with the 20 EMA near $0.65, the 50 EMA around $0.71, and the 200 EMA near $0.74. Source: TradingView This showed that sellers still controlled the bigger trend. The RSI showed momentum was weak and nowhere close to a bullish reversal zone. Moreover, the CMF was slightly below zero again, so capital inflows had not stepped back in yet. Overall, ADA looked stuck in a slow drift, with no strong sign that buyers were returning. |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 23:00
6mo ago
|
XRP Chart Turns Neutral, Repeated $2.55 Rejections Define Next Breakout Zone | cryptonews |
XRP
|
|
|
Traders are closely monitoring the $2.49 support level, as sustained closes below could lead to further declines.Updated Nov 3, 2025, 4:01 a.m. Published Nov 3, 2025, 4:00 a.m.
(CoinDesk Data) What to know: XRP fell 1.2% to $2.49, facing strong resistance at $2.55 amid heavy institutional activity.The digital asset's trading was dominated by technical flows, with volume surging 85% above the recent average.Traders are closely monitoring the $2.49 support level, as sustained closes below could lead to further declines.XRP slipped below the $2.50 mark during Tuesday’s session, falling 1.2% to $2.49 as repeated rejections at $2.55 confirmed strong resistance. The decline came on heavy institutional activity, with volume surging 85% above the recent average as sellers consolidated control at the upper end of XRP’s trading range. News BackgroundThe digital asset traded between $2.49–$2.55 over the 24-hour session, with price action dominated by technical flows rather than fundamental drivers.Three failed breakout attempts at $2.54–$2.55 defined the session’s tone, each accompanied by elevated sell-side volume.Overall activity climbed 85% above the 7-day average, as total turnover reached 50.3 million tokens during the decline — confirming institutional-scale distribution at resistance levels.Market sentiment remains mixed after recent gains, with traders watching whether XRP can maintain support above $2.49 amid broader consolidation in high-beta crypto assets.Price Action SummaryXRP’s 24-hour session saw price fluctuate within a $0.07 range, stabilizing near $2.497 after dipping to intraday lows of $2.49. The 60-minute chart revealed brief attempts to reclaim $2.50.This behavior suggests institutional reaccumulation around the $2.50 mark — a level historically associated with short-term liquidity traps. Despite the pullback, buyers have defended the psychological floor through multiple retests.However, market microstructure analysis shows a shift in momentum as sell orders cluster above $2.54, limiting near-term upside until volume profiles realign with prior bullish patterns.Technical AnalysisThe session’s repeated rejections at $2.55 confirmed a developing lower-high formation on daily charts, indicating fading momentum following October’s rally.The $2.50 support continues to act as a key psychological and structural pivot; maintaining closes above this threshold remains essential for preserving the medium-term bullish bias.Momentum indicators, including RSI and MACD, hover near neutral territory, suggesting a potential pause phase rather than outright reversal.Volume concentration at upper resistance levels — particularly the 50.3M spike during the selloff — confirms active profit-taking from larger holders. Declining volume in the subsequent consolidation implies early signs of accumulation, with institutional buyers potentially layering bids near the $2.49–$2.50 zone.What Traders Should WatchXRP’s near-term trajectory hinges on whether the $2.49 support can withstand further tests. Sustained closes below this level could open downside toward $2.46, while a clean breakout above $2.55 would reset short-term sentiment and target the $2.60 extension.Traders are watching for confirmation through volume alignment: expansion on upward moves would validate renewed demand, while continued fading activity would reinforce a range-bound outlook.Until directional confirmation emerges, positioning remains tactical — with liquidity pockets at $2.49–$2.50 offering short-term opportunities for both mean-reversion and breakout traders.More For You OwlTing: Stablecoin Infrastructure for the Future Oct 16, 2025 Stablecoin payment volumes have grown to $19.4B year-to-date in 2025. OwlTing aims to capture this market by developing payment infrastructure that processes transactions in seconds for fractions of a cent. View Full Report More For You Asia Morning Briefing: Cautious Calm Returns to BTC Markets as Traders Rebuild Risk 2 hours ago BTC holds near $110K and Ethereum trades around $3,900 as liquidations ease and market makers report clients slowly re-entering risk after the Fed-driven selloff. What to know: Bitcoin and Ether begin the week trading above $110,000 and $3,880 respectively, despite a significant decline over the past 30 days.FlowDesk notes traders are cautiously buying BTC, HYPE, and SYRUP tokens, while Solana-linked assets lag.Crypto derivatives saw $155 million liquidated, indicating a moderate flush of overleveraged longs rather than panic selling.Read full story Top Stories |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 23:03
6mo ago
|
Aster Token Soars 30% After Changpeng Zhao Reveals $2.5 Million Personal Stake | cryptonews |
ASTER
|
|
|
ADVERTISEMENT
Ethereum News Ethereum’s $165 Billion Stablecoin Surge Positions It as a Global Digital Reserve Power by Bhavesh November 3, 2025 Blockchain News Publicly Traded Firm Adds $20 Million in Solana, Expands Holdings Beyond 2.3 Million SOL October 30, 2025 Cryptocurrency News Blockworks Faces Backlash After DeFiLlama Data Resale Allegations and Staff Layoffs October 30, 2025 Bitcoin News Bitcoin Rally Loses Whale Support as Retail Takeover Signals Possible Consolidation October 29, 2025 Bitcoin News Ethereum News Ethereum’s $165 Billion Stablecoin Surge Positions It as a Global Digital Reserve Power by Bhavesh November 3, 2025 0 Ethereum’s network has achieved a remarkable milestone, with stablecoins issued on its blockchain amassing approximately $165 billion in reserves, surpassing... Read moreDetails Noomez Tokenomics and the Anti-Dump Promise: How Vested Team Tokens Prevent Early Price Shocks Memes in Charge: La Culex Presale Outshines Dogecoin and SHIB in Best Meme Coin Today $MOBU, LTC, and SOL: Which is the Top Crypto to Invest in 2025 For Maximum Profits, Lightning-Fast Growth, and Next-Level ROI MoonBull Captures Investor Attention in the Best Crypto Presale to Buy Now as AVAX and XLM Build Momentum for 2025 Ethereum News Ethereum News Ethereum’s $165 Billion Stablecoin Surge Positions It as a Global Digital Reserve Power by Bhavesh November 3, 2025 0 Ethereum’s network has achieved a remarkable milestone, with stablecoins issued on its blockchain amassing approximately $165 billion in reserves, surpassing... Read moreDetails Ethereum Fails to Hold $4,000 Support as Correction Gathers Pace SharpLink Gaming Adds $80 Million in Ethereum to Its Strategic Reserve Ethereum Price Gains Momentum, Bulls Eye Break Above $3,800 Resistance ETH Breaks $4,100: What’s Next for Ethereum Investors? Blockchain News Blockchain News Publicly Traded Firm Adds $20 Million in Solana, Expands Holdings Beyond 2.3 Million SOL by Hiren Patel October 30, 2025 0 A publicly listed company with a strong focus on the Solana ecosystem has made another significant investment this month, purchasing... Read moreDetails $3 Million XRP Hack Exposes Recovery-Firm Predators: More Than 95 % May Be Exploitative Charles Hoskinson Addresses Allegations of Misusing Cardano Treasury Funds XRP Faces Heavy Pressure as $242 Million Exits Major Wallets Is XRP Building Its Next Rally? Chart Signals Mirror 2017 Accumulation Crypto News Cryptocurrency News Blockworks Faces Backlash After DeFiLlama Data Resale Allegations and Staff Layoffs by Bhavesh October 30, 2025 0 A heated dispute erupted in the crypto data community after DeFiLlama founder 0xngmi accused Blockworks of reselling DeFiLlama’s free data... Read moreDetails Zcash (ZEC) Soars After Arthur Hayes Predicts $10,000 Target BNB Rises Nearly 5% as President Donald Trump Pardons Binance Founder Changpeng Zhao Binance Tightens Security, Bans 600+ Accounts Linked to Unfair Trading Tools Charles Hoskinson Addresses Allegations of Misusing Cardano Treasury Funds Altcoin News Tether Acquires 4,812 BTC for $458.7M to Boost Twenty One Capital’s Holdings Binance Coin (BNB) Struggles at $730 Resistance—Breakout or Reversal? Tether vs. Circle: A Battle for Stablecoin Dominance Amid U.S. Crypto Regulation Crackdown Bloomberg Predicts ETF Approval for Litecoin and Hedera Over Solana and XRP Stablecoin Market Nears $200B, Expected to Double by 2025 Latest News Blockworks Faces Backlash After DeFiLlama Data Resale Allegations and Staff Layoffs Zcash (ZEC) Soars After Arthur Hayes Predicts $10,000 Target SharpLink Gaming Adds $80 Million in Ethereum to Its Strategic Reserve BNB Rises Nearly 5% as President Donald Trump Pardons Binance Founder Changpeng Zhao Changpeng Zhao (CZ) Fires Back at Peter Schiff, Says Bitcoin’s Critics Ignore Its 16-Year Growth Memecoin News Dogecoin Slumps 10% to $0.17 as Whales Dump $74 Million Despite Merger Buzz Dogecoin Crashes 25% as $57 Million Exits Market — Can the Memecoin Rebound? Dogecoin Eyes $0.25 Breakout as ETF Buzz and Whale Accumulation Strengthen Bullish Outlook Fight Fight Fight LLC Plans Massive Digital Asset Treasury for TRUMP Token Dogecoin Holds Strong as Ichimoku Indicators Signal Bullish Momentum NFT News Metaverse Shows Signs of Life as NFT Sales Surge 27% in August Bybit to Shut Down NFT Marketplace as Industry Decline Continues Xterio (XTER) Price Analysis: Navigating the Blockchain Gaming Landscape Pudgy Penguins NFTs Hit $102,600 as Ecosystem Token Launch Looms Pizza Ninjas NFT Collection Honors Bitcoin’s First Real-World Purchase ADVERTISEMENT Price Prediction Price Prediction Dogecoin Price Prediction 2024-2030: DOGE Forecast August 7, 2024 Price Prediction Shiba Inu Price Prediction: 2024, 2025, 2026-2030 Forecast August 7, 2024 Price Prediction (BTC) Bitcoin Price Prediction 2024, 2025–2030 August 5, 2024 Price Prediction Toncoin Price Prediction: 2024, 2025, 2030 | Forecast August 5, 2024 Press Release Press Release Noomez Tokenomics and the Anti-Dump Promise: How Vested Team Tokens Prevent Early Price Shocks November 3, 2025 Press Release Memes in Charge: La Culex Presale Outshines Dogecoin and SHIB in Best Meme Coin Today November 3, 2025 Press Release $MOBU, LTC, and SOL: Which is the Top Crypto to Invest in 2025 For Maximum Profits, Lightning-Fast Growth, and Next-Level ROI November 3, 2025 Press Release MoonBull Captures Investor Attention in the Best Crypto Presale to Buy Now as AVAX and XLM Build Momentum for 2025 November 2, 2025 Ethereum’s $165 Billion Stablecoin Surge Positions It as a Global Digital Reserve Power by Bhavesh November 3, 2025 0 Ethereum’s network has achieved a remarkable milestone, with stablecoins issued on its blockchain amassing approximately $165 billion in reserves, surpassing... Noomez Tokenomics and the Anti-Dump Promise: How Vested Team Tokens Prevent Early Price Shocks by PR Manager November 3, 2025 0 The journey of Noomez Tokenomics is more than just numbers; it’s a carefully engineered ecosystem designed to reward believers while protecting holders... Memes in Charge: La Culex Presale Outshines Dogecoin and SHIB in Best Meme Coin Today by PR Manager November 3, 2025 0 If you think your portfolio has more red than a stop sign, don’t worry, Bitcoin just slipped under $110,000, so... $MOBU, LTC, and SOL: Which is the Top Crypto to Invest in 2025 For Maximum Profits, Lightning-Fast Growth, and Next-Level ROI by PR Manager November 3, 2025 0 What if a single crypto could change the game for early investors this year? Ever wondered which cryptocurrency could explode... Load More ADVERTISEMENT |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 23:06
6mo ago
|
Bitcoin Breaks Down Again — Bearish Momentum Intensifies Across Crypto Market | cryptonews |
BTC
|
|
|
Bitcoin price is again declining below $110,000. BTC could continue to move down if it stays below the $110,000 resistance.
Bitcoin started a fresh decline below the $109,500 support. The price is trading below $109,000 and the 100 hourly Simple moving average. There is a bearish trend line forming with resistance at $109,800 on the hourly chart of the BTC/USD pair (data feed from Kraken). The pair might continue to move down if it trades below the $107,400 zone. Bitcoin Price Faces Rejection Bitcoin price failed to stay above the $110,500 pivot level and started a fresh decline. BTC dipped below $110,000 and $109,500 to enter a bearish zone. The decline was such that the price traded below the 50% Fib retracement level of the upward move from the $106,312 swing low to the $111,000 high. Besides, there is a bearish trend line forming with resistance at $109,800 on the hourly chart of the BTC/USD pair. Bitcoin is now trading below $109,000 and the 100 hourly Simple moving average. If the bulls attempt a fresh increase, the price could face resistance near the $109,500 level. The first key resistance is near the $109,800 level and the trend line. Source: BTCUSD on TradingView.com The next resistance could be $110,500. A close above the $110,500 resistance might send the price further higher. In the stated case, the price could rise and test the $111,200 resistance. Any more gains might send the price toward the $113,500 level. The next barrier for the bulls could be $115,000 and $115,500. More Losses In BTC? If Bitcoin fails to rise above the $109,800 resistance zone, it could continue to move down. Immediate support is near the $107,400 level or the 76.4% Fib retracement level of the upward move from the $106,312 swing low to the $111,000 high. The first major support is near the $106,500 level. The next support is now near the $105,500 zone. Any more losses might send the price toward the $104,200 support in the near term. The main support sits at $103,500, below which BTC might struggle to recover in the short term. Technical indicators: Hourly MACD – The MACD is now gaining pace in the bearish zone. Hourly RSI (Relative Strength Index) – The RSI for BTC/USD is now below the 50 level. Major Support Levels – $107,400, followed by $106,500. Major Resistance Levels – $109,800 and $110,500. |
|||||
|
2025-11-03 04:20
6mo ago
|
2025-11-02 23:11
6mo ago
|
DOGE Falls to $0.18 as Long-Term Holders Exit, 'Death Cross' Price Action Appears | cryptonews |
DOGE
|
|
|
DOGE Falls to $0.18 as Long-Term Holders Exit, 'Death Cross' Price Action AppearsThe decline came amid a deteriorating technical backdrop and increased selling activity across large wallets.Updated Nov 3, 2025, 4:11 a.m. Published Nov 3, 2025, 4:11 a.m.
Dogecoin slipped 2.3% to $0.1827 during Tuesday’s trading session, breaking decisively below key support at $0.1830 as whale distribution accelerated and long-term holders began exiting positions. The decline came amid a deteriorating technical backdrop and increased selling activity across large wallets. STORY CONTINUES BELOW News BackgroundDOGE dropped from $0.1870 to $0.1827 across the 24-hour window, carving out a $0.0070 range that marked its third consecutive session of lower highs. Price Action SummaryThe decline followed three failed recovery attempts above $0.1860, solidifying resistance at that level. Heavy distribution persisted throughout the U.S. trading window as algorithmic activity amplified sell pressure. While short-term traders attempted to defend $0.1830, long-term wallet data showed a sharp behavioral shift — a clear rotation from accumulation to liquidation. On-chain metrics confirmed the move: 440 million DOGE were offloaded by mid-tier whales (holding 10M-100M tokens) over a 72-hour period. The Hodler Net Position Change metric recorded 22 million DOGE outflows, a 36% reversal from prior accumulation trends and the largest drawdown in nearly a month. Technical AnalysisDogecoin’s technical structure has transitioned into a confirmed bearish trend following the breach of $0.1830 support. A “death-cross” pattern between the 50-day and 200-day EMAs formed in late October, while the 100-day EMA is on track for a similar cross — both reinforcing downside bias. Cost-basis analysis places heavy liquidity between $0.177-$0.179, where roughly 3.78 billion tokens are concentrated. This area now represents the next critical defense zone for bulls. Meanwhile, volume analysis highlights sustained institutional activity: the 274.3M turnover spike and subsequent 15.5M burst during the selloff suggest distribution may be entering its final stage before potential base formation. What Traders Should WatchDOGE trades in a vulnerable position following the breakdown. The $0.1830-$0.1850 band remains the immediate pivot zone, while failure to defend $0.177 could trigger a move toward $0.14 — the next meaningful liquidity pocket. Analysts warn that only a sustained reclaim of $0.1860 accompanied by above-average volume would negate the current bearish setup. Until then, traders are treating short-term rallies as exit opportunities rather than trend reversals. Whale activity remains the key watchpoint: any sharp decline in large-transaction counts would signal the end of the distribution phase and the start of potential accumulation near cost-basis support. More For You OwlTing: Stablecoin Infrastructure for the Future Oct 16, 2025 Stablecoin payment volumes have grown to $19.4B year-to-date in 2025. OwlTing aims to capture this market by developing payment infrastructure that processes transactions in seconds for fractions of a cent. View Full Report More For You XRP Chart Turns Neutral, Repeated $2.55 Rejections Define Next Breakout Zone 15 minutes ago Traders are closely monitoring the $2.49 support level, as sustained closes below could lead to further declines. What to know: XRP fell 1.2% to $2.49, facing strong resistance at $2.55 amid heavy institutional activity.The digital asset's trading was dominated by technical flows, with volume surging 85% above the recent average.Traders are closely monitoring the $2.49 support level, as sustained closes below could lead to further declines.Read full story |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:07
6mo ago
|
Binance Completes ApeCoin Contract Swap on BNB Smart Chain | cryptonews |
APE
BNB
|
|
|
3 mins mins
Key Points: Binance swaps ApeCoin at 1:1 ratio, BNB Smart Chain enhancement.No trading disruptions; old APE now termed APEOLD.Exchange smoothly completed swap with uninterrupted services. Binance finalized a contract swap for ApeCoin on the BNB Smart Chain, enabling a 1:1 exchange rate for new APE tokens, effective November 3, 2025. This move enhances security and operational efficiency in managing ApeCoin transactions without interrupting trading services. Binance Executes Seamless ApeCoin Swap at 1:1 Ratio Binance announced the completion of its contract swap for ApeCoin on its platform, with the process starting in late October 2025. Users can exchange old APE tokens at a 1:1 ratio for new APE tokens, maintaining a seamless transaction process. The original APE token has been renamed APEOLD and is no longer supported for withdrawals. With the transition, APE’s operational chain moved to the BNB Smart Chain, enabling enhanced security and streamlined contract functionality. The migration occurred without any disruptions to trading services, underscoring the platform’s emphasis on minimizing user impact. The exchange handled the swap automatically, reinforcing their record of efficient user-centric adaptations. The BNB Smart Chain now gains cross-chain liquidity options due to upgraded APE smart contract operations, potentially increasing overall BEP20 token utility. “Withdrawing availability of new APE tokens will be announced separately after the contract swap is completed. The original APE token will be renamed APEOLD, and withdrawals of APEOLD will no longer be supported. Trading services remain unaffected,” according to Binance’s official announcement.Market participants largely received the transition well, reflecting on Binance’s history of smooth token migrations. There was no public commentary from major industry figures, reflecting the procedural nature of the migration. As part of its official communication, Binance confirmed the immediate operational changes with precision and clarity. As highlighted by Coincu, the migration aligns with broader trends in enhancing cryptocurrency infrastructure efficiency on exchanges. ApeCoin Moves to BNB Smart Chain Amid Infrastructure Upgrades Did you know? The automatic migration of ApeCoin to the BNB Smart Chain is similar to Ethereum’s previous protocol upgrades, showcasing a longstanding industry practice for enhancing infrastructure security and functionality. According to CoinMarketCap, ApeCoin (APE) recently traded at $0.40, with a market cap of formatNumber(303998715, 2) and a market dominance of 0.01%. Its trading volume over 24 hours stood at nearly formatNumber(20904343, 2). The token showed price declines, notably a 29.92% drop over 90 days. ApeCoin(APE), daily chart, screenshot on CoinMarketCap at 01:02 UTC on November 3, 2025. Source: CoinMarketCap Users likely expect improved efficiency and enhanced transaction security following the upgrade. This transition plays into the wider strategy of enhancing the BNB ecosystem to support decentralized applications effectively. DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing. Rate this post |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:16
6mo ago
|
Bitcoin Consolidates Near $110K as Technical Indicators Signal Neutral Momentum | cryptonews |
BTC
|
|
|
Lawrence Jengar
Nov 03, 2025 02:16 BTC price holds steady at $109,673.76 down 0.3% as traders assess mixed technical signals while awaiting fresh catalysts to drive direction from current consolidation zone. Quick Take • BTC trading at $109,673.76 (down 0.3% in 24h) • Trading on technical factors in absence of major catalysts • Price testing support above key 200-day moving average at $109,849 • Bitcoin following broader crypto market sideways action Market Events Driving Bitcoin Price Movement No significant news events have emerged in the past 48 hours to drive major BTC price movement. Bitcoin technical analysis shows the market is trading primarily on technical factors as institutional and retail traders assess current price levels near psychological resistance around $110,000. The modest 0.30% decline reflects typical weekend consolidation patterns, with BTC price action remaining within established trading ranges. Trading volume of $1.44 billion on Binance spot markets indicates moderate participation levels, suggesting traders are positioning cautiously ahead of the new trading week. Without fresh fundamental catalysts, market participants are focusing on technical levels and chart patterns to guide short-term trading decisions. This environment typically sees increased sensitivity to technical support and resistance zones. BTC Technical Analysis: Neutral Consolidation Phase Price Action Context BTC price currently trades just below the 20-day simple moving average at $110,008, indicating short-term consolidation after recent weakness. The cryptocurrency sits above the critical 200-day moving average at $109,849, maintaining longer-term bullish structure despite near-term pressure. Bitcoin's position relative to moving averages shows mixed signals, with the 7-day SMA at $110,166 providing immediate resistance while the 50-day SMA at $113,678 represents a more significant overhead challenge. Volume patterns suggest institutional interest remains moderate during this consolidation phase. Key Technical Indicators The RSI reading of 45.10 places Bitcoin in neutral territory, neither oversold nor overbought, providing flexibility for movement in either direction. This RSI level typically indicates balanced buying and selling pressure. MACD histogram shows a positive reading of 69.44, suggesting potential bullish momentum despite the overall MACD remaining negative at -1003.12. This divergence often precedes trend changes and warrants close monitoring. Bollinger Bands positioning shows BTC price at 46% of the band range, indicating room for movement toward either the upper band at $114,218 or lower band at $105,799. Critical Price Levels for Bitcoin Traders Immediate Levels (24-48 hours) • Resistance: $111,250 (24-hour high and immediate technical ceiling) • Support: $109,366 (24-hour low and key psychological level) Breakout/Breakdown Scenarios A break below the $109,366 support could trigger selling toward the $103,528 level, where stronger support is expected. Conversely, clearing resistance at $111,250 would target the $116,400 zone where more significant overhead pressure awaits. The daily ATR of $3,352 suggests traders should expect potential moves of this magnitude in either direction during active trading sessions. BTC Correlation Analysis Bitcoin correlation patterns show the cryptocurrency trading independently of major traditional assets in the current environment. Without significant macro economic events, BTC price movements are primarily driven by crypto-specific factors rather than broader market sentiment. The cryptocurrency market is showing typical weekend consolidation characteristics, with most major assets trading in tight ranges. This pattern often precedes increased volatility as the new trading week begins and institutional participation increases. Trading Outlook: Bitcoin Near-Term Prospects Bullish Case A sustained move above $111,250 resistance could signal renewed buying interest, targeting the $116,400 level. Strong volume accompanying any breakout would validate upside momentum and potentially attract additional institutional buying. The positive MACD histogram provides early indication of potential momentum shifts, though confirmation through price action remains necessary. Bearish Case Failure to hold the $109,366 support level could accelerate selling pressure toward $103,528, where stronger buyers are expected to emerge. Extended weakness below the 200-day moving average would challenge the longer-term bullish structure. Risk Management Current volatility suggests stop-losses should account for the $3,352 ATR, with positions sized accordingly. Traders should monitor volume patterns for confirmation of any directional moves beyond current consolidation ranges. The neutral RSI provides flexibility for both long and short positioning, though risk-reward ratios favor waiting for clear directional signals before committing to larger positions. Image source: Shutterstock btc price analysis btc price prediction |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:28
6mo ago
|
BNB Tests Support at $1,066 as Technical Momentum Weakens Despite Recent $1,000+ Breakthrough | cryptonews |
BNB
|
|
|
Rongchai Wang
Nov 03, 2025 02:28 Binance Coin retreats 2.1% to $1,066.41 after breaking above $1,000 last week, with technical indicators suggesting consolidation phase as MACD turns bearish amid broader crypto market uncertainty. Quick Take • BNB trading at $1,066.41 (down 2.1% in 24h) • Technical consolidation following last week's breakthrough above $1,000 milestone • Price testing lower Bollinger Band support at $1,047 level • Following broader crypto weakness as Bitcoin faces headwinds Market Events Driving Binance Coin Price Movement Trading on technical factors dominates BNB price action today, with no significant news events in the past 48 hours affecting the token's trajectory. The most recent catalyst remains October 30th's breakthrough above $1,000, when BNB surged past $1,100 amid renewed investor confidence following Binance's regulatory clarity achievements. The momentum from that technical milestone appears to be cooling, with BNB price consolidating in a tighter range as traders digest the recent gains. Volume on Binance spot markets reached $160.9 million in 24 hours, indicating steady institutional interest despite the pullback from recent highs. Kyrgyzstan's partnership with Binance to launch a national stablecoin continues to provide fundamental support for the BNB ecosystem, though immediate price impact has been absorbed into the broader technical pattern. The A5A7 stablecoin operating on BNB Chain represents a significant adoption milestone that traders are monitoring for longer-term implications. BNB Technical Analysis: Consolidation Phase Price Action Context BNB price currently trades below all short-term moving averages, with the 7-day SMA at $1,089 and 20-day SMA at $1,103 providing immediate resistance levels. The token's position at $1,066 represents a 31% gain above its 200-day moving average of $812, indicating the long-term bullish trend remains intact despite recent weakness. Volume patterns suggest institutional participants are maintaining positions rather than aggressively selling, supporting the consolidation narrative over a significant reversal. The Binance Coin technical analysis reveals a healthy pullback after the explosive move through $1,000 resistance. Key Technical Indicators The RSI reading of 44.58 places BNB in neutral territory, providing room for movement in either direction without extreme overbought or oversold conditions. This balanced momentum reading suggests the recent decline represents profit-taking rather than fundamental weakness. MACD indicators show concerning bearish divergence, with the histogram at -8.20 indicating strengthening downward momentum. However, the relatively shallow penetration below the signal line suggests this could be a temporary correction rather than a trend reversal. Stochastic oscillators paint a more cautious picture, with %K at 16.48 indicating oversold conditions that could attract buying interest from technical traders monitoring these levels. Critical Price Levels for Binance Coin Traders Immediate Levels (24-48 hours) • Resistance: $1,094 (24-hour high and 7-day moving average confluence) • Support: $1,047 (Bollinger Band lower boundary and psychological level) Breakout/Breakdown Scenarios A break below $1,047 support could trigger additional selling toward the $1,021 level, where stronger support from previous consolidation areas may emerge. Conversely, reclaiming $1,094 resistance would signal renewed buying interest and potential retest of the $1,110-$1,120 zone. The broader $1,000 level now serves as major psychological support, with significant buying interest likely to emerge on any test of this round number that triggered the recent rally. BNB Correlation Analysis Bitcoin's weakness today contributes to BNB's decline, with the leading cryptocurrency facing its own technical challenges that ripple through altcoin markets. However, BNB's correlation to Bitcoin remains moderate, allowing for independent price discovery based on Binance-specific developments. Traditional market factors show limited direct impact on BNB price today, though Federal Reserve policy expectations continue influencing broader risk asset sentiment. The recent Powell remarks suggesting economic stabilization provide a generally supportive backdrop for cryptocurrency markets. Trading Outlook: Binance Coin Near-Term Prospects Bullish Case Reclaiming the $1,094-$1,103 resistance zone would signal renewed technical strength and potential move toward $1,150-$1,180 targets mentioned by analysts following the $1,000 breakthrough. Strong volume on any bounce would confirm institutional support for higher prices. Bearish Case Failure to hold $1,047 support could trigger algorithmic selling toward $1,021, with a more significant breakdown potentially testing the psychologically important $1,000 level. Extended weakness in Bitcoin markets poses additional downside risk. Risk Management Conservative traders should consider $1,040 as a stop-loss level for long positions, representing a clear break of technical support. Position sizing should account for BNB's daily ATR of $60, indicating significant intraday volatility potential that requires appropriate risk controls. Image source: Shutterstock bnb price analysis bnb price prediction |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:30
6mo ago
|
Bitwise Turns Ultra Bullish on Solana With Bitcoin-Like Upside and Institutional Heat | cryptonews |
SOL
|
|
|
Bitwise is intensifying its conviction in Solana, viewing SOL as the prime beneficiary of institutional inflows, tokenization growth, and real-world adoption driven by unmatched speed, scalability, and unstoppable developer and market momentum.
|
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:34
6mo ago
|
XRP Tests Support at $2.46 as Technical Consolidation Continues Below Key Moving Averages | cryptonews |
XRP
|
|
|
Ted Hisokawa
Nov 03, 2025 02:34 XRP price trades at $2.46 down 1.9% as Ripple technical analysis shows consolidation below the 50-day MA amid neutral RSI and modest bullish MACD divergence in quiet market conditions. Quick Take • XRP trading at $2.46 (down 1.9% in 24h) • Technical consolidation in absence of major catalysts • Testing support near 20-day moving average at $2.47 • Following broader crypto weakness with Bitcoin declining Market Events Driving Ripple Price Movement Trading on technical factors in absence of major catalysts characterizes the current XRP price action. No significant news events have emerged in the past 48 hours affecting Ripple's fundamental outlook, leaving technical analysis as the primary driver for short-term price movements. The modest 1.87% decline reflects the broader cryptocurrency market sentiment, with XRP maintaining its correlation to Bitcoin's downward pressure. Trading volume on Binance spot reached $145.7 million over 24 hours, indicating steady institutional interest despite the lack of newsworthy developments. Market participants appear to be positioning ahead of potential breakout scenarios, with XRP price consolidating in a relatively tight range between $2.45 and $2.55 throughout the session. XRP Technical Analysis: Neutral Consolidation Phase Price Action Context Ripple technical analysis reveals XRP trading slightly below its 20-day simple moving average of $2.47, while remaining well below the 50-day SMA at $2.70. This positioning suggests ongoing consolidation after previous gains, with the cryptocurrency finding itself in a neutral technical zone. The current price structure shows XRP holding above the lower Bollinger Band at $2.27 but struggling to reclaim the middle band, which aligns with the 20-day moving average. Volume patterns suggest institutional accumulation continues, though without the momentum needed for immediate breakout attempts. Key Technical Indicators The daily RSI of 43.86 sits firmly in neutral territory, providing room for movement in either direction without indicating oversold or overbought conditions. This neutral RSI reading suggests balanced buying and selling pressure at current levels. MACD analysis shows modest bullish divergence with the histogram turning positive at 0.0137, though the main MACD line remains below the signal line. This technical setup indicates potential for upward momentum building beneath the surface, requiring confirmation through price action above key resistance levels. Critical Price Levels for Ripple Traders Immediate Levels (24-48 hours) • Resistance: $2.70 (50-day moving average confluence) • Support: $2.19 (immediate technical support from recent consolidation) Breakout/Breakdown Scenarios A break below $2.19 support could trigger further weakness toward the strong support zone at $1.25, representing the lower boundary of the current bullish trend structure. Such a breakdown would require heavy volume confirmation and likely coincide with broader crypto market weakness. Conversely, reclaiming the $2.70 resistance level would target the stronger resistance at $3.14, potentially setting up a test of the 52-week high at $3.55. This upside scenario requires sustained buying pressure and favorable broader market conditions. XRP Correlation Analysis Bitcoin's declining price action continues to influence XRP price movements, with Ripple maintaining its typical correlation to the broader cryptocurrency market leader. The correlation remains particularly strong during risk-off periods, as observed in today's synchronized weakness. Traditional market factors show limited direct impact on current XRP price action, though any significant S&P 500 volatility could influence cryptocurrency sentiment broadly. Gold's performance appears disconnected from immediate Ripple price dynamics in the current environment. Trading Outlook: Ripple Near-Term Prospects Bullish Case A sustained break above $2.70 resistance accompanied by expanding volume could trigger momentum toward $3.14 and potentially the 52-week highs. The positive MACD histogram supports this scenario if broader crypto sentiment improves and Bitcoin stabilizes. Bearish Case Failure to hold the $2.19 support level on increased volume would signal deeper correction potential toward $1.25. Continued Bitcoin weakness and risk-off sentiment in traditional markets represent the primary catalysts for this downside scenario. Risk Management Conservative traders should consider stop-losses below $2.19 for long positions, while aggressive traders might use the $2.27 lower Bollinger Band as a tighter stop. Position sizing should account for the current 14-day ATR of $0.14, suggesting potential daily volatility of approximately 5.7% from current levels. Image source: Shutterstock xrp price analysis xrp price prediction |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:34
6mo ago
|
Asia Morning Briefing: Cautious Calm Returns to BTC Markets as Traders Rebuild Risk | cryptonews |
BTC
|
|
|
BTC holds near $110K and Ethereum trades around $3,900 as liquidations ease and market makers report clients slowly re-entering risk after the Fed-driven selloff.
Nov 3, 2025, 1:34 a.m. Good Morning, Asia. Here's what's making news in the markets:Welcome to Asia Morning Briefing, a daily summary of top stories during U.S. hours and an overview of market moves and analysis. For a detailed overview of U.S. markets, see CoinDesk's Crypto Daybook Americas. Bitcoin BTC$108,385.33 is trading above $110,000, and Ether is at $3,880 as Hong Kong begins its business week. STORY CONTINUES BELOW Both major digital assets are down significantly in the last 30 days, with BTC in the red by 10% and ETH 14% as traders continue to consolidate positions. In a note, market maker FlowDesk said that its clients have mostly paused adding new risk after last week’s Federal Reserve meeting, with flows dominated by short-term trading strategies and portfolio rebalancing. Still, they wrote in the note, traders showed net buying in BTC, HYPE, and SYRUP, tokens supported by cashflow or buyback narratives, even as Solana-linked assets lagged alongside a rise in Bitcoin dominance to roughly 60%. FlowDesk wrote that many traders now appear underexposed if the market rebounds, suggesting cleaner positioning after earlier deleveraging. In the derivatives market, however, fear remains the prevailing mood. Roughly $155 million in crypto derivatives were liquidated over the past 24 hours, according to CoinGlass data, with $97 million in long positions and $58 million in shorts wiped out. The pattern suggests a moderate flush of overleveraged longs rather than broad panic selling, as funding rates and borrowing costs continue to normalize. FlowDesk observed elevated put skew and lingering caution despite calmer volatility, while call selling and put buying dominated both BTC and ETH options. Cheap risk reversals could appeal if spot markets stabilize, FlowDesk wrote, with volatility likely to drift lower into year-end. On the credit side, borrowing demand for altcoins remains strong as traders exploit negative funding and hedge locked tokens, while benchmark lending rates for DeFi protocols on Ethereum have eased to 5.3% from 5.6%. Overall, crypto markets begin the week in a wait-and-see mode, looking for a catalyst that has yet to materialize. Market MovementBTC: Bitcoin held steady around $110,300 on Monday, showing signs of stabilization after a week of profit-taking and modest deleveraging across derivatives markets. ETH: Ether traded near $3,900, edging higher as traders cautiously rebuilt exposure following last week’s market-wide pullback. Gold: Gold closed at about $4,003 per ounce, easing 0.5% Friday after rebounding from a two-week low earlier in the week. Despite hawkish Federal Reserve comments and a stronger dollar cutting December rate-cut odds, the metal still gained 3.7% in October for its third straight monthly rise as geopolitical tension and U.S. fiscal uncertainty kept haven demand intact. Nikkei 225: Japan’s main stock index continues to push above 52,000 as investors are optimistic about U.S. - China trade developments and solid earnings from tech giants. Elsewhere in CryptoCanaan’s Japan deal marks first state-linked bitcoin mining project in the country (The Block)November Could Be the New October for U.S. Crypto ETFs After Shutdown Delays SEC Decisions (CoinDesk)Court Denies Crypto Bank Custodia's Bid to Pry Master Account From Unwilling Fed (Decrypt)More For You OwlTing: Stablecoin Infrastructure for the Future Oct 16, 2025 Stablecoin payment volumes have grown to $19.4B year-to-date in 2025. OwlTing aims to capture this market by developing payment infrastructure that processes transactions in seconds for fractions of a cent. View Full Report More For You ASTER Zooms 20% as Binance's CZ Purchases 2M Tokens 12 hours ago ASTER is a rebranded derivative platform token with a max supply of 8 billion, focusing on community incentives and decentralized exchange features. What to know: DEX token ASTER surged nearly 20% after Binance founder Changpeng Zhao purchased 2 million tokens, sparking speculative demand.ASTER is a rebranded derivative platform token with a max supply of 8 billion, focusing on community incentives and decentralized exchange features.Despite the rally, traders should be cautious due to high token supply, competition, and a narrative-driven price increase.Read full story |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:36
6mo ago
|
OKX to Facilitate Centrifuge (CFG) Crypto Migration Process | cryptonews |
CFG
|
|
|
Terrill Dicki
Nov 03, 2025 02:36 OKX announces support for Centrifuge's CFG token migration. Deposits and withdrawals will be temporarily suspended, but trading remains unaffected. In a significant move for the Centrifuge (CFG) ecosystem, OKX has announced its support for the migration of CFG tokens, as per the official plan outlined by Centrifuge. The migration process will see a temporary suspension of deposits and withdrawals, starting from 2:00 am UTC on November 3, 2025, according to the official announcement from OKX. Migration Schedule and Impact The scheduled migration is set to occur between 2:00 am UTC on November 3 and 12:00 pm UTC on November 4, 2025. OKX has committed to completing the migration within this timeframe. However, users are advised that coordination with the project team and other involved parties may cause potential delays. Importantly, the trading of CFG will not be affected during this migration period. This ensures that users can continue trading without interruption while the backend processes are underway. Post-Migration Changes Following the successful completion of the migration, OKX will reinstate CFG deposits and withdrawals. However, it will no longer support deposits of the old token. Only deposits of the new token, identifiable by the contract address 0xcccccccccc33d538dbc2ee4feab0a7a1ff4e8a94, will be accepted. Users are urged to ensure they are depositing the new token to avoid any potential losses. Context and Implications This migration aligns with Centrifuge's strategic initiatives to enhance its blockchain infrastructure. By moving to a new token contract, Centrifuge aims to improve security and scalability, which are crucial for supporting its growing ecosystem. The broader crypto community is watching this migration closely, as successful execution could set a precedent for similar projects considering token upgrades. OKX's involvement underscores its commitment to supporting blockchain innovation and providing its users with seamless access to updated digital assets. Conclusion As the migration unfolds, stakeholders in the Centrifuge community and users on the OKX platform are encouraged to stay informed and exercise caution during the transition. For more detailed information, the official announcement can be accessed on OKX. Image source: Shutterstock okx centrifuge cfg crypto migration |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:39
6mo ago
|
ADA Tests Critical $0.59 Support as $2.3B Liquidity Exit Weighs on Cardano Price | cryptonews |
ADA
|
|
|
Peter Zhang
Nov 03, 2025 02:39 Cardano trades at $0.59 after losing $2.3 billion in liquidity over four days, with technical indicators suggesting potential recovery from oversold conditions. Quick Take • ADA trading at $0.59 (down 3.5% in 24h) • $2.3 billion liquidity exit over four days pressures price action • Testing critical long-term support at lower Bollinger Band • Following broader crypto weakness as Bitcoin declines Market Events Driving Cardano Price Movement The primary catalyst behind ADA's recent decline has been a significant liquidity drain, with over $2.3 billion exiting the market over just four days. This massive outflow forced ADA price to retest long-term support levels that have held multiple times throughout 2025, creating the current technical setup at $0.59. While some analysts maintain bullish long-term projections with targets reaching $10 during the next bull cycle, these predictions have had minimal impact on immediate price action. The market appears focused on near-term technical factors rather than speculative future targets, with traders prioritizing risk management over aspirational calls. The absence of significant fundamental catalysts in recent days has left ADA price vulnerable to technical selling pressure and broader market sentiment shifts. ADA Technical Analysis: Oversold Conditions Emerge Price Action Context ADA price currently trades below all major moving averages, with the 7-day SMA at $0.62 providing immediate resistance. The 20-day and 50-day SMAs have converged around $0.64-$0.74, creating a significant resistance zone that bulls must reclaim for any meaningful recovery. Trading volume on Binance spot remains elevated at $38 million, suggesting continued institutional and retail interest despite the price decline. This volume profile indicates that the current support test is drawing buyer attention. Key Technical Indicators The RSI at 34.48 has moved into oversold territory without reaching extreme levels, suggesting potential for a relief bounce. More encouraging is the MACD histogram showing a small bullish divergence at 0.0007, indicating momentum may be shifting despite the overall bearish MACD reading of -0.0376. The Stochastic oscillator at 3.26 sits in deeply oversold conditions, historically a zone where ADA has found short-term buying interest. Cardano technical analysis suggests these momentum indicators are aligned for a potential bounce if support holds. Critical Price Levels for Cardano Traders Immediate Levels (24-48 hours) • Resistance: $0.62 (7-day SMA and recent session high) • Support: $0.59 (current Bollinger Band lower boundary and session low) Breakout/Breakdown Scenarios A break below $0.59 support could trigger selling toward the $0.54 yearly low, with strong support not appearing until the $0.27 level. Conversely, reclaiming $0.62 would target the 20-day SMA at $0.64, with the $0.72 level representing the next significant resistance zone. ADA Correlation Analysis • Bitcoin: ADA price is following Bitcoin's weakness, maintaining typical beta correlation during risk-off periods • Traditional markets: Limited correlation to equity markets currently, with crypto-specific factors dominating • Sector peers: Underperforming relative to other layer-1 protocols during the recent pullback Trading Outlook: Cardano Near-Term Prospects Bullish Case A successful defense of $0.59 support combined with oversold momentum indicators could spark a relief rally toward $0.62-$0.64. Volume expansion above $50 million would confirm renewed buying interest and support higher targets. Bearish Case Failure to hold $0.59 opens the door to further downside, particularly if Bitcoin continues declining. The next major support at $0.54 represents the yearly low and a critical test for long-term holders. Risk Management Short-term traders should consider stops below $0.58 to limit downside exposure, while longer-term holders may view current levels as accumulation opportunities given the oversold technical picture. Position sizing should account for ADA's 14-day ATR of $0.04, representing roughly 7% daily volatility. Image source: Shutterstock ada price analysis ada price prediction |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:44
6mo ago
|
Aster token goes flying after CZ reveals $2.5M personal stake | cryptonews |
ASTER
|
|
|
The native token for the decentralized exchange protocol Aster spiked over 30% on Sunday after Binance co-founder Changpeng “CZ” Zhao disclosed that he now holds over $2.5 million in Aster.
CZ shared his wallet holdings in an X post on Sunday, and said he bought “some Aster today, using my own money on Binance.” “I am not a trader. I buy and hold,” he added. The post prompted Aster to jump from $0.91 to a peak of $1.26, according to CoinGecko. At time of publication, it was trading at $1.22. Source: Changpeng ZhaoPrivacy-focused cryptocurrency Zcash experienced a similar bump last week off the back of an endorsement from another influential name in the space, rising 30% hours after crypto entrepreneur Arthur Hayes predicted the token would eventually reach $10,000. Traders follow CZ piling into Aster The post led to a notable jump in Aster’s trading volume over the last 24 hours, with data from analytics platform DefiLlama showing it has risen from $224 million to over $2 billion. The tokens market capitalization has also grown in step with its other key metrics, rising from $1.8 billion to over $2.5 billion. A trader under the handle “Gold” announced on X that they had opened a position in Aster after CZ’s post, explaining it was the first time CZ had ever announced buying a token outside of BNB. Source: Gold“CZ, the most influential figure in crypto and creator of the largest platform in crypto announced his purchase of ASTER with personal funds. That’s it. Don’t overthink it,” they added. Soon after the spike, CZ addressed the situation and said, “damn, I was hoping to buy some more at low prices,” and that he doesn’t “buy tokens often,” other than Aster and BNB eight years ago, which he still holds. Whales are shorting Aster Not everyone is convinced that the rally will last, though. Two whales are betting against CZ and shorting Aster in the hope that the price will go down. One trader built up their Aster short to 42.97 million tokens, worth $52.8 million, with a liquidation price of $2, blockchain analytics platform Lookonchain said on Sunday. Source: LookonchainAnother trader also decided to bet against the rally and increased their short position to 15.3 million Aster, worth $19.1 million, with a liquidation price of $2.11. CZ’s connection to AsterIn September, CZ congratulated Aster on X, writing he thought the project was off to a good start and encouraged the developers to “keep building,” though there were questions about how closely CZ was tied to the project. What is known is that CZ’s family office, YZi Labs, formerly known as Binance Labs, invested in Aster’s predecessor, Astherus, last year. Aster was born out of a merger between Astherus and decentralized perpetuals protocol APX Finance in late 2024. In September, a BNB Chain representative told Cointelegraph that Aster received support from BNB Chain and YZi Labs, but did not disclose whether CZ was directly involved. Magazine: Grokipedia: ‘Far right talking points’ or much-needed antidote to Wikipedia? |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:45
6mo ago
|
Solana Revenue Growth Story Overshadowed by Tariff-Induced Market Selloff as SOL Tests $183 Support | cryptonews |
SOL
|
|
|
Rebeca Moen
Nov 03, 2025 02:45 SOL price drops to $183.81 amid broader crypto liquidation cascade triggered by tariff announcements, despite reporting 30x faster revenue growth than early Ethereum. Quick Take • SOL trading at $183.81 (down 0.9% in 24h) • Tariff announcement triggers crypto-wide selloff despite positive Solana fundamentals • Testing critical support above 200-day moving average at $179.78 • Following Bitcoin's weakness amid risk-off sentiment in traditional markets Market Events Driving Solana Price Movement The SOL price has been caught in a broader cryptocurrency liquidation cascade following former President Trump's announcement of 100% tariffs on Chinese imports earlier this week. This macroeconomic shock has overshadowed what would otherwise be considered highly bullish news for the Solana ecosystem. Despite the revenue milestone announced on October 30th showing Solana's annual revenue reaching $2.85 billion - growing 30 times faster than Ethereum's early stages - the SOL price has struggled to maintain momentum above $190. The tariff-induced market volatility has created what analysts describe as a "liquidation cascade" that has affected all risk assets, including cryptocurrencies. The delayed SEC approval of Solana ETFs from major asset managers including Bitwise, 21Shares, and Franklin Templeton has added to near-term uncertainty, though analysts maintain a 90-95% probability of eventual approval. This regulatory delay has removed a potential positive catalyst that could have helped SOL price weather the broader market storm. SOL Technical Analysis: Testing Key Support Confluence Price Action Context SOL price currently trades below all major short-term moving averages, with the 7-day SMA at $188.26 and 20-day SMA at $189.34 acting as immediate resistance. However, the token remains above its crucial 200-day moving average at $179.78, suggesting the longer-term uptrend remains intact despite recent weakness. The Solana technical analysis reveals a market in consolidation mode, with SOL price trading within its Bollinger Bands and showing a %B position of 0.2376, indicating proximity to the lower band without a decisive breakdown. Key Technical Indicators The daily RSI at 41.55 sits in neutral territory but approaching oversold levels, potentially setting up a bounce scenario. The MACD histogram shows a slight bullish divergence at 0.2131, suggesting selling pressure may be waning despite the negative MACD reading of -4.9783. Stochastic indicators (%K at 23.93, %D at 31.52) signal oversold conditions, typically indicating potential reversal opportunities for short-term traders. Critical Price Levels for Solana Traders Immediate Levels (24-48 hours) • Resistance: $189.34 (20-day moving average and psychological level) • Support: $179.78 (200-day moving average and crucial trend support) Breakout/Breakdown Scenarios A break below the $179.78 support could trigger a deeper correction toward the $174.06 level, potentially reaching the stronger support zone at $168.79. Conversely, reclaiming $189 would target the $208.91 resistance level, where the 50-day moving average currently sits. SOL Correlation Analysis • Bitcoin: SOL price is following Bitcoin's weakness closely, with both assets struggling under macroeconomic pressure from tariff concerns • Traditional markets: High correlation with risk-off sentiment affecting both crypto and equity markets • Sector peers: Performing in line with other Layer-1 tokens, suggesting sector-wide rather than Solana-specific selling pressure Trading Outlook: Solana Near-Term Prospects Bullish Case The fundamental backdrop remains strong with record revenue growth and pending ETF approvals. A successful defense of the $179.78 support, combined with any improvement in macro sentiment, could trigger a sharp reversal toward $200+. The oversold technical readings suggest limited downside risk at current levels. Bearish Case Continued macro headwinds and a break below 200-day moving average support could extend the correction toward $168-170. Any escalation in trade tensions or broader crypto market liquidations remain key risks to monitor. Risk Management Conservative traders should consider stops below $178 to protect against a breakdown of key technical support. Given the current daily ATR of $11.33, position sizing should account for continued elevated volatility in the near term. Image source: Shutterstock sol price analysis sol price prediction |
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:48
6mo ago
|
Analyst Identifies the Key Zone XRP Must Revisit Before Full Recovery Above $3 | cryptonews |
XRP
|
|
|
XRP is showing renewed signs of volatility as it attempts to stabilize following its sharp drop earlier in October. Despite a brief recovery, the broader market weakness has kept the token from regaining strong upward momentum.
|
|||||
|
2025-11-03 03:20
6mo ago
|
2025-11-02 20:51
6mo ago
|
DOGE Tests $0.18 Support as Fed Rate Cut Uncertainty Triggers 8% Weekly Decline | cryptonews |
DOGE
|
|
|
Felix Pinkston
Nov 03, 2025 02:51 Dogecoin trades at $0.18 after Fed Chair Powell's hawkish comments sparked broader crypto selloff, with DOGE price testing critical support amid $2B volume surge. Quick Take • DOGE trading at $0.18 (down 3.5% in 24h) • Fed rate cut uncertainty triggers 8.4% weekly decline • Price testing lower Bollinger Band support at $0.18 • Following Bitcoin's broader crypto market weakness Market Events Driving Dogecoin Price Movement Federal Reserve Chair Jerome Powell's indication that a December rate cut is not guaranteed has emerged as the primary catalyst behind Dogecoin's recent price weakness. DOGE price declined 8.4% to $0.18 following Powell's comments citing persistent inflation concerns, marking the most significant weekly decline for the meme coin in recent months. The Fed's hawkish stance was compounded by President Trump's trade comments regarding China, which raised additional inflationary concerns among investors. This macro backdrop has created a challenging environment for risk assets, with Dogecoin bearing the brunt of crypto market selling pressure. Despite the price decline, Dogecoin technical analysis reveals encouraging signs of institutional interest. Trading volume spiked 60% to surpass $2 billion in total value traded, indicating that both retail buyers and large holders remain active even amid the current uncertainty. This volume surge suggests accumulation patterns may be forming at current price levels. DOGE Technical Analysis: Testing Critical Support Zone Price Action Context DOGE price currently trades below all major moving averages, with the 7-day SMA at $0.19 providing immediate resistance. The coin sits precariously near the lower Bollinger Band at $0.18, representing a critical juncture for short-term price direction. Dogecoin's position relative to Bitcoin shows correlation with the broader crypto market's risk-off sentiment. Volume analysis from Binance spot data indicates increased institutional interest, with the $92.4 million in 24-hour volume representing above-average trading activity. This suggests smart money may be positioning for a potential bounce from current support levels. Key Technical Indicators The RSI reading of 37.37 places Dogecoin in neutral territory but approaching oversold conditions, which historically has preceded short-term bounces. The MACD histogram shows a slight positive reading of 0.0003, indicating early signs of bullish momentum divergence despite the negative MACD line. Stochastic indicators present a more bearish picture, with %K at 11.17 suggesting DOGE price remains in oversold territory. However, this extreme reading often coincides with reversal opportunities for contrarian traders. Critical Price Levels for Dogecoin Traders Immediate Levels (24-48 hours) • Resistance: $0.19 (7-day SMA and Bollinger Band middle) • Support: $0.18 (lower Bollinger Band and current pivot) Breakout/Breakdown Scenarios A break below $0.18 support could trigger further selling toward the $0.16-$0.17 zone, where longer-term trend line support converges. Conversely, a reclaim of $0.19 resistance would target the $0.20 upper Bollinger Band, potentially triggering short covering. DOGE Correlation Analysis Dogecoin continues following Bitcoin's lead, with both assets experiencing similar selling pressure from macro uncertainty. The correlation remains strong as institutional flows treat DOGE as a risk asset alongside other cryptocurrencies. Traditional markets show mixed signals, with the S&P 500's reaction to Fed comments providing additional context for crypto weakness. Gold's performance suggests flight-to-safety flows are competing with risk assets like Dogecoin for investor attention. Trading Outlook: Dogecoin Near-Term Prospects Bullish Case A hold above $0.18 support combined with Bitcoin stabilization could spark a relief rally toward $0.21 resistance. The elevated volume profile suggests sufficient liquidity exists for such a move, particularly if Fed concerns begin to subside. Bearish Case Failure to hold $0.18 opens the door to deeper correction toward $0.16, where stronger technical support converges with the 200-day moving average zone. Continued macro headwinds represent the primary downside risk. Risk Management Traders should consider stops below $0.175 for long positions, with position sizing reflecting the current elevated volatility environment. The daily ATR of $0.01 suggests swing traders should account for typical daily ranges when setting targets and stops. Image source: Shutterstock doge price analysis doge price prediction |
|||||